| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 2.29e-08 | 38 | 256 | 8 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | KIF21B MYH9 MYH10 MYH11 MYO10 ACTC1 MYO3A KIF15 DYNC1H1 MYO1B KIF20A MYH14 | 3.91e-08 | 118 | 256 | 12 | GO:0003774 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B MYH9 MYH10 MYH11 HSP90B2P ATAD5 MYO10 DHX38 ACTC1 MCM6 MYO3A KIF15 RAD54B DYNC1H1 TTF2 ABCC1 NVL ATP6V1G1 MYO1B KIF20A IQCA1 MYH14 ABCC12 ATP1A1 FIGNL1 HSPA14 | 1.04e-07 | 614 | 256 | 26 | GO:0140657 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH9 MYH10 MYH11 MYO10 OBSCN ADD2 MYO3A SCN5A CNGA2 STRN3 MYO1B EEF1A1 MYH14 UNC13C | 1.73e-06 | 230 | 256 | 14 | GO:0005516 |
| GeneOntologyMolecularFunction | ADP binding | 2.47e-06 | 48 | 256 | 7 | GO:0043531 | |
| GeneOntologyMolecularFunction | phosphopyruvate hydratase activity | 8.25e-06 | 4 | 256 | 3 | GO:0004634 | |
| GeneOntologyMolecularFunction | histone binding | TBL1Y TSPY3 TSPY9 TSPY2 TSPY1 SUPT6H CARM1 TSPY4 TSPY8 TBL1XR1 PWP1 TSPY10 HDAC2 | 4.04e-05 | 265 | 256 | 13 | GO:0042393 |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.60e-04 | 120 | 256 | 8 | GO:0008013 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF21B HSP90B2P ATAD5 DHX38 MCM6 KIF15 DYNC1H1 ABCC1 NVL ATP6V1G1 KIF20A IQCA1 ABCC12 ATP1A1 FIGNL1 HSPA14 | 1.95e-04 | 441 | 256 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 4.01e-04 | 49 | 256 | 5 | GO:0005547 | |
| GeneOntologyMolecularFunction | plus-end directed microfilament motor activity | 4.87e-04 | 3 | 256 | 2 | GO:0060002 | |
| GeneOntologyMolecularFunction | actin filament binding | 7.26e-04 | 227 | 256 | 10 | GO:0051015 | |
| GeneOntologyBiologicalProcess | gonadal mesoderm development | 1.28e-12 | 9 | 251 | 7 | GO:0007506 | |
| GeneOntologyBiologicalProcess | NADH regeneration | 4.45e-06 | 21 | 251 | 5 | GO:0006735 | |
| GeneOntologyBiologicalProcess | canonical glycolysis | 4.45e-06 | 21 | 251 | 5 | GO:0061621 | |
| GeneOntologyBiologicalProcess | glucose catabolic process to pyruvate | 4.45e-06 | 21 | 251 | 5 | GO:0061718 | |
| GeneOntologyBiologicalProcess | NAD catabolic process | 1.12e-05 | 25 | 251 | 5 | GO:0019677 | |
| GeneOntologyBiologicalProcess | glycolytic process through glucose-6-phosphate | 1.12e-05 | 25 | 251 | 5 | GO:0061620 | |
| GeneOntologyBiologicalProcess | glycolytic process through fructose-6-phosphate | 3.36e-05 | 31 | 251 | 5 | GO:0061615 | |
| GeneOntologyBiologicalProcess | glucose catabolic process | 3.95e-05 | 32 | 251 | 5 | GO:0006007 | |
| GeneOntologyBiologicalProcess | mesenchyme development | AMER1 ACTA1 TSPY3 ACTC1 TSPY9 TSPY2 TSPY1 BMP5 WNT8A TSPY4 LAMA5 TSPY8 TSPY10 CDH2 HDAC2 | 5.51e-05 | 372 | 251 | 15 | GO:0060485 |
| GeneOntologyBiologicalProcess | chromatin remodeling | TET2 HDAC9 ZNF274 TSPY3 TSPY9 TSPY2 TSPY1 TASOR2 EHMT2 SUPT6H RAD54B CDY2A HCFC2 CARM1 TTF2 TSPY4 DYRK1A TSPY8 RIF1 TSPY10 PRDM16 HDAC2 | 1.14e-04 | 741 | 251 | 22 | GO:0006338 |
| GeneOntologyCellularComponent | myosin II filament | 1.82e-06 | 3 | 256 | 3 | GO:0097513 | |
| GeneOntologyCellularComponent | phosphopyruvate hydratase complex | 7.20e-06 | 4 | 256 | 3 | GO:0000015 | |
| GeneOntologyCellularComponent | myosin complex | 7.54e-06 | 59 | 256 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin filament | 1.15e-05 | 25 | 256 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH9 MYH10 MYH11 MYO10 ACTA1 ACTC1 DGKH ADD2 MYO3A KALRN DYRK1A MYO1B SPECC1L EEF1A1 MICALL2 MYH14 PEAK1 CROCC CDH2 | 9.56e-05 | 576 | 256 | 19 | GO:0015629 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | MYH9 MYH10 MYH11 MYO3A FCHSD2 MYO15B MYO1B ITLN2 CUBN MYH14 PCMT1 | 1.01e-04 | 223 | 256 | 11 | GO:0098862 |
| GeneOntologyCellularComponent | brush border | 1.10e-04 | 152 | 256 | 9 | GO:0005903 | |
| GeneOntologyCellularComponent | myosin II complex | 3.57e-04 | 28 | 256 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | neuromuscular junction | 4.62e-04 | 112 | 256 | 7 | GO:0031594 | |
| GeneOntologyCellularComponent | filopodium | 8.09e-04 | 123 | 256 | 7 | GO:0030175 | |
| MousePheno | omphalocele | 6.50e-06 | 53 | 188 | 7 | MP:0003052 | |
| Domain | IQ_motif_EF-hand-BS | MYH9 MYH10 MYH11 MYO10 OBSCN MYO3A MYO15B SCN5A MYO1B IQCA1 MYH14 CEP131 | 2.52e-09 | 90 | 248 | 12 | IPR000048 |
| Domain | IQ | MYH9 MYH10 MYH11 MYO10 OBSCN MYO3A MYO15B SCN5A MYO1B IQCA1 MYH14 CEP131 | 3.71e-09 | 93 | 248 | 12 | PS50096 |
| Domain | IQ | MYH9 MYH10 MYH11 MYO10 OBSCN MYO3A SCN5A MYO1B IQCA1 MYH14 CEP131 | 9.69e-09 | 81 | 248 | 11 | SM00015 |
| Domain | Myosin_head_motor_dom | 2.99e-08 | 38 | 248 | 8 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.99e-08 | 38 | 248 | 8 | PS51456 | |
| Domain | Myosin_head | 2.99e-08 | 38 | 248 | 8 | PF00063 | |
| Domain | MYSc | 2.99e-08 | 38 | 248 | 8 | SM00242 | |
| Domain | IQ | 4.04e-07 | 71 | 248 | 9 | PF00612 | |
| Domain | Enolase_N | 2.31e-06 | 3 | 248 | 3 | PF03952 | |
| Domain | Enolase | 2.31e-06 | 3 | 248 | 3 | IPR000941 | |
| Domain | Enolase_C | 2.31e-06 | 3 | 248 | 3 | IPR020810 | |
| Domain | Enolase_N | 2.31e-06 | 3 | 248 | 3 | IPR020811 | |
| Domain | Enolase_CS | 2.31e-06 | 3 | 248 | 3 | IPR020809 | |
| Domain | Enolase_C | 2.31e-06 | 3 | 248 | 3 | PF00113 | |
| Domain | Enolase_N | 2.31e-06 | 3 | 248 | 3 | SM01193 | |
| Domain | Enolase_C | 2.31e-06 | 3 | 248 | 3 | SM01192 | |
| Domain | ENOLASE | 2.31e-06 | 3 | 248 | 3 | PS00164 | |
| Domain | - | 9.16e-06 | 4 | 248 | 3 | 3.30.390.10 | |
| Domain | - | 9.16e-06 | 4 | 248 | 3 | 3.20.20.120 | |
| Domain | Enolase_C-like | 9.16e-06 | 4 | 248 | 3 | IPR029065 | |
| Domain | Enolase_N-like | 9.16e-06 | 4 | 248 | 3 | IPR029017 | |
| Domain | P-loop_NTPase | KIF21B MYH9 MYH10 MYH11 ATAD5 MYO10 DHX38 MCM6 NOD2 MYO3A MYO15B KIF15 RAD54B NLRC5 DYNC1H1 TTF2 ABCC1 EFL1 NVL MYO1B EEF1A1 KIF20A ARHGAP5 IQCA1 MYH14 ABCC12 FIGNL1 | 2.45e-05 | 848 | 248 | 27 | IPR027417 |
| Domain | Myosin_N | 3.69e-05 | 15 | 248 | 4 | PF02736 | |
| Domain | Myosin_N | 3.69e-05 | 15 | 248 | 4 | IPR004009 | |
| Domain | NAP_family | 6.30e-05 | 17 | 248 | 4 | IPR002164 | |
| Domain | NAP | 6.30e-05 | 17 | 248 | 4 | PF00956 | |
| Domain | WD40_repeat_CS | KIF21B AAMP TBL1Y EIPR1 HERC1 ATG16L1 STRN3 WDR31 TBL1XR1 PWP1 | 6.98e-05 | 164 | 248 | 10 | IPR019775 |
| Domain | WD40_repeat | KIF21B AAMP TBL1Y EIPR1 DMXL1 TECPR2 HERC2 HERC1 ATG16L1 STRN3 WDR31 TBL1XR1 PWP1 | 7.46e-05 | 272 | 248 | 13 | IPR001680 |
| Domain | Myosin_tail_1 | 8.02e-05 | 18 | 248 | 4 | PF01576 | |
| Domain | Myosin_tail | 8.02e-05 | 18 | 248 | 4 | IPR002928 | |
| Domain | WD_REPEATS_1 | KIF21B AAMP TBL1Y EIPR1 DMXL1 TECPR2 HERC2 HERC1 ATG16L1 STRN3 WDR31 TBL1XR1 PWP1 | 9.30e-05 | 278 | 248 | 13 | PS00678 |
| Domain | WD_REPEATS_2 | KIF21B AAMP TBL1Y EIPR1 DMXL1 TECPR2 HERC2 HERC1 ATG16L1 STRN3 WDR31 TBL1XR1 PWP1 | 9.64e-05 | 279 | 248 | 13 | PS50082 |
| Domain | WD_REPEATS_REGION | KIF21B AAMP TBL1Y EIPR1 DMXL1 TECPR2 HERC2 HERC1 ATG16L1 STRN3 WDR31 TBL1XR1 PWP1 | 9.64e-05 | 279 | 248 | 13 | PS50294 |
| Domain | Myosin-like_IQ_dom | 1.01e-04 | 19 | 248 | 4 | IPR027401 | |
| Domain | - | 1.01e-04 | 19 | 248 | 4 | 4.10.270.10 | |
| Domain | - | KIF21B AAMP TBL1Y EIPR1 BIRC6 DMXL1 TECPR2 HERC1 ATG16L1 STRN3 WDR31 SPAG9 TBL1XR1 PWP1 | 1.55e-04 | 333 | 248 | 14 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | KIF21B AAMP TBL1Y EIPR1 BIRC6 DMXL1 TECPR2 HERC1 ATG16L1 STRN3 WDR31 SPAG9 TBL1XR1 PWP1 | 1.65e-04 | 335 | 248 | 14 | IPR015943 |
| Domain | Pr_beta_C | 1.76e-04 | 2 | 248 | 2 | PF12465 | |
| Domain | Proteasome_bsu_C | 1.76e-04 | 2 | 248 | 2 | IPR024689 | |
| Domain | Wnt8 | 1.76e-04 | 2 | 248 | 2 | IPR013301 | |
| Domain | WD40_repeat_dom | KIF21B AAMP TBL1Y EIPR1 DMXL1 TECPR2 HERC1 ATG16L1 STRN3 WDR31 SPAG9 TBL1XR1 PWP1 | 1.79e-04 | 297 | 248 | 13 | IPR017986 |
| Domain | ARM-type_fold | INTS1 PSMD2 TOGARAM1 NCBP1 PKP1 ULK4 USP35 DOCK8 ODAD2 VIRMA RSPRY1 RIF1 MROH6 CTNND2 | 1.86e-04 | 339 | 248 | 14 | IPR016024 |
| Domain | WD40 | KIF21B AAMP TBL1Y EIPR1 DMXL1 TECPR2 HERC1 ATG16L1 STRN3 WDR31 TBL1XR1 PWP1 | 2.57e-04 | 268 | 248 | 12 | SM00320 |
| Domain | EGF_Ca-bd_CS | 3.11e-04 | 97 | 248 | 7 | IPR018097 | |
| Domain | EGF_CA | 3.53e-04 | 99 | 248 | 7 | PS01187 | |
| Domain | WTX | 5.22e-04 | 3 | 248 | 2 | PF09422 | |
| Domain | TECPR | 5.22e-04 | 3 | 248 | 2 | SM00706 | |
| Domain | Uncharacterised_FAM123 | 5.22e-04 | 3 | 248 | 2 | IPR019003 | |
| Domain | Beta-propeller_rpt_TECPR | 5.22e-04 | 3 | 248 | 2 | IPR006624 | |
| Domain | FBN | 5.22e-04 | 3 | 248 | 2 | IPR011398 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.34e-04 | 106 | 248 | 7 | IPR000152 | |
| Domain | WD40 | KIF21B AAMP TBL1Y EIPR1 DMXL1 HERC1 ATG16L1 STRN3 WDR31 TBL1XR1 PWP1 | 7.18e-04 | 259 | 248 | 11 | PF00400 |
| Domain | LRR_6 | 8.03e-04 | 55 | 248 | 5 | PF13516 | |
| Domain | G-protein_beta_WD-40_rep | 9.40e-04 | 85 | 248 | 6 | IPR020472 | |
| Domain | EGF_CA | 1.00e-03 | 86 | 248 | 6 | PF07645 | |
| Domain | ARM-like | PSMD2 TOGARAM1 PKP1 ULK4 USP35 DOCK8 ODAD2 RSPRY1 RIF1 MROH6 CTNND2 | 1.01e-03 | 270 | 248 | 11 | IPR011989 |
| Domain | AAA | 1.03e-03 | 34 | 248 | 4 | PS00674 | |
| Domain | G8_domain | 1.04e-03 | 4 | 248 | 2 | IPR019316 | |
| Domain | G8 | 1.04e-03 | 4 | 248 | 2 | PS51484 | |
| Domain | G8 | 1.04e-03 | 4 | 248 | 2 | SM01225 | |
| Domain | G8 | 1.04e-03 | 4 | 248 | 2 | PF10162 | |
| Domain | EGF_CA | 1.23e-03 | 122 | 248 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.35e-03 | 124 | 248 | 7 | IPR001881 | |
| Domain | Laminin_domII | 1.71e-03 | 5 | 248 | 2 | IPR010307 | |
| Domain | Hexokinase_2 | 1.71e-03 | 5 | 248 | 2 | PF03727 | |
| Domain | Myosin_S1_N | 1.71e-03 | 5 | 248 | 2 | IPR008989 | |
| Domain | Hexokinase_BS | 1.71e-03 | 5 | 248 | 2 | IPR019807 | |
| Domain | Perilipin | 1.71e-03 | 5 | 248 | 2 | PF03036 | |
| Domain | Laminin_aI | 1.71e-03 | 5 | 248 | 2 | IPR009254 | |
| Domain | Laminin_I | 1.71e-03 | 5 | 248 | 2 | PF06008 | |
| Domain | Laminin_II | 1.71e-03 | 5 | 248 | 2 | PF06009 | |
| Domain | Hexokinase_C | 1.71e-03 | 5 | 248 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 1.71e-03 | 5 | 248 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 1.71e-03 | 5 | 248 | 2 | PF00349 | |
| Domain | Perilipin | 1.71e-03 | 5 | 248 | 2 | IPR004279 | |
| Domain | HEXOKINASE_2 | 1.71e-03 | 5 | 248 | 2 | PS51748 | |
| Domain | HEXOKINASE_1 | 1.71e-03 | 5 | 248 | 2 | PS00378 | |
| Domain | ASX_HYDROXYL | 2.17e-03 | 100 | 248 | 6 | PS00010 | |
| Domain | Hexokinase | 2.54e-03 | 6 | 248 | 2 | IPR001312 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 1.38e-06 | 45 | 178 | 7 | M39474 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 3.30e-06 | 51 | 178 | 7 | MM15928 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 1.25e-05 | 62 | 178 | 7 | M11521 | |
| Pathway | WP_METABOLIC_EPILEPTIC_DISORDERS | 1.92e-05 | 91 | 178 | 8 | M48079 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | TBL1Y PSMB7 PSMB10 PSMD2 SH3BP4 EHMT2 CREB3L3 DYNC1H1 CARM1 ABCC1 EGLN2 MAP2K4 ID1 ATP6V1G1 TBL1XR1 AR EEF1A1 HSPA14 | 7.16e-05 | 505 | 178 | 18 | MM15548 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 8.21e-05 | 19 | 178 | 4 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 8.21e-05 | 19 | 178 | 4 | M27489 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 9.80e-05 | 85 | 178 | 7 | M1870 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 1.02e-04 | 20 | 178 | 4 | M18415 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.24e-04 | 21 | 178 | 4 | M27494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.80e-04 | 23 | 178 | 4 | MM15222 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 2.14e-04 | 24 | 178 | 4 | M2243 | |
| Pathway | WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM | 2.14e-04 | 24 | 178 | 4 | M45511 | |
| Pathway | REACTOME_GLUCONEOGENESIS | 2.96e-04 | 26 | 178 | 4 | M13748 | |
| Pathway | BIOCARTA_D4GDI_PATHWAY | 4.00e-04 | 12 | 178 | 3 | M15513 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 4.40e-04 | 142 | 178 | 8 | MM15576 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 4.56e-04 | 29 | 178 | 4 | M27309 | |
| Pathway | REACTOME_ADIPOGENESIS | 4.85e-04 | 110 | 178 | 7 | M48259 | |
| Pathway | BIOCARTA_D4GDI_PATHWAY | 5.16e-04 | 13 | 178 | 3 | MM1380 | |
| Pubmed | MYH9 AMER1 HK1 RSL1D1 MCAM BIRC6 CEMIP2 DMXL1 TASOR2 SH3BP4 CDCA2 ZC3H11A EHMT2 VPS13A HCFC2 DYNC1H1 AFF2 GOPC PODXL SPAG9 SPECC1L SLC3A2 PPM1G CRB1 KIF20A RIF1 CEP131 PEAK1 ATP1A1 PCCB | 2.79e-13 | 777 | 261 | 30 | 35844135 | |
| Pubmed | MYH9 MYH10 HK1 RSL1D1 DHX38 INTS1 PSMD2 NCBP1 MCM6 BIRC6 TASOR2 ZC3H11A SUPT6H DLD HERC2 DYNC1H1 NVL MYO1B SPAG9 VIRMA PPM1G PWP1 RIF1 MYH14 TLN1 ATP1A1 HDAC2 | 9.57e-13 | 653 | 261 | 27 | 22586326 | |
| Pubmed | KIF21B KIFBP MYH9 MYH10 TRIO TBL1Y TTC3 LUZP1 PARP1 KIF15 EHMT2 HERC2 DYNC1H1 CARM1 STRN3 MAP2K4 KALRN ZNF618 DYRK1A GRIK2 SPECC1L TBL1XR1 VIRMA EEF1A1 LRP1 CEP131 CTNND2 UBASH3B ENO1 CDH2 HDAC2 | 1.18e-11 | 963 | 261 | 31 | 28671696 | |
| Pubmed | TRIO RSL1D1 ACTA1 OBSCN ACTC1 SPART TTC3 BIRC6 EHMT2 SUPT6H NFIL3 MED13 KALRN SHB LAMA2 ZNF835 EEF1A1 MYH14 TLN1 ATP1A1 ENO1 ENO3 | 3.66e-11 | 497 | 261 | 22 | 23414517 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRIO MYO10 INTS1 SREBF1 OBSCN PSMB10 EXOSC8 PTCH1 TTC3 BIRC6 SH3BP4 GGT7 NOD2 RHPN1 ZC3H11A SCN5A NLRC5 ULK4 HERC2 HERC1 MED13 DYNC1H1 ARAP1 SLC37A3 KALRN DYRK1A LAMA5 MROH6 ADAMTS7 TLN1 CEP131 PRDM16 | 8.03e-11 | 1105 | 261 | 32 | 35748872 |
| Pubmed | MYH10 TRIO ATAD5 DHX38 ACTA1 MCAM PSMD2 NCBP1 BIRC6 CEMIP2 LUZP1 ADD2 CDCA2 PARP1 KIF15 VPS13A PPP1R37 HERC2 HERC1 KNL1 ABCC1 EFL1 GOPC MYO1B SPAG9 SLC3A2 PPM1G ARHGAP5 RIF1 CEP131 PEAK1 | 9.90e-11 | 1049 | 261 | 31 | 27880917 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KIFBP MYH9 MYH10 HK1 TRIO RSL1D1 DHX38 PSMD2 NCBP1 MCM6 TTC3 SPDL1 CDCA2 PARP1 ZC3H11A GCLC SUPT6H PKP1 DLD DYNC1H1 ADGRA3 NRDC LARS1 MYO1B CBS SLC3A2 EEF1A1 PWP1 RIF1 MYH14 TLN1 PEAK1 ATP1A1 ENO1 SOAT1 PCMT1 | 2.09e-10 | 1425 | 261 | 36 | 30948266 |
| Pubmed | MYH9 MYH10 MYH11 ACTA1 ACTC1 PSMD2 LUZP1 DYNC1H1 MYO1B SPECC1L EEF1A1 MYH14 ENO1 ENO2 | 2.36e-10 | 191 | 261 | 14 | 33762435 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | HSP90B2P TRIO RSL1D1 CARMIL3 TUBGCP2 DMXL1 SUPT6H PKP1 DLD HERC2 KALRN NVL GRIK2 TBL1XR1 PPM1G ARHGAP5 ENO1 ENO2 ENO3 PCMT1 | 6.98e-10 | 475 | 261 | 20 | 31040226 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | AAMP KIFBP MYH9 HK1 DHX38 ACTA1 PSMB7 PSMD2 NCBP1 MCM6 BIRC6 SPDL1 KIF15 GCLC DLD STK39 HERC1 DYNC1H1 CARM1 ATG16L1 STRN3 EFL1 GOPC NRDC LARS1 ATP6V1G1 SPAG9 TBL1XR1 CBS PPM1G EEF1A1 MYH14 TLN1 CROCC ENO2 | 1.38e-09 | 1455 | 261 | 35 | 22863883 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | MYH9 MYH10 GALNT2 RSL1D1 ACTC1 LUZP1 PARP1 DYNC1H1 ATG16L1 LARS1 MYO1B SPECC1L SLC3A2 ATP1A1 ENO1 | 2.26e-09 | 268 | 261 | 15 | 33024031 |
| Pubmed | TET2 MYH10 TBL1Y ATAD5 RSL1D1 PSMB7 PSMD2 ZNF217 CDCA2 RNF214 FBN1 EHMT2 NFKBIE NIP7 DLD HCFC2 HERC2 HERC1 DYNC1H1 NPAT LARS1 MYO1B SPAG9 TBL1XR1 PPM1G PWP1 RIF1 MYH14 CEP131 ATP1A1 PCCB PRDM16 PCMT1 HDAC2 | 3.19e-09 | 1429 | 261 | 34 | 35140242 | |
| Pubmed | MYH9 MYH10 MYH11 HSP90B2P HK1 TRIO ACTA1 PSMD2 ITGA2 LUZP1 ADD2 PARP1 DLD DYNC1H1 STRN3 MAP2K4 NRDC KALRN DOCK8 LARS1 DYRK1A SPECC1L VIRMA SLC3A2 EEF1A1 ARHGAP5 MYH14 TLN1 PEAK1 ATP1A1 CTNND2 CROCC CDH2 ENO2 | 3.31e-09 | 1431 | 261 | 34 | 37142655 | |
| Pubmed | MYH9 MYH10 MYH11 AMER1 HK1 RSL1D1 ACTA1 ACTC1 ANKRD30B PSMD2 NCBP1 TTC3 LUZP1 TASOR2 CDCA2 PARP1 GCLC NIP7 VPS13A PKHD1 DLD PPIP5K2 PLIN1 MED13 STRN3 SHB ATP6V1G1 MYO1B SLC3A2 EEF1A1 MYH14 ATP1A1 ENO1 HDAC2 | 4.00e-09 | 1442 | 261 | 34 | 35575683 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GALNT2 RSL1D1 ACTA1 INTS1 ACTC1 PSMD2 NCBP1 MCM6 PARP1 ZC3H11A SUPT6H PKP1 HERC2 DYNC1H1 LARS1 MYO1B SPECC1L SLC3A2 EEF1A1 RIF1 CCN1 MYH14 TLN1 CEP131 ATP1A1 ENO1 PCMT1 HDAC2 | 4.66e-09 | 1024 | 261 | 28 | 24711643 |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | MYH9 MYH10 MYH11 ACTA1 ACTC1 PARP1 DLD DYNC1H1 MYO1B EEF1A1 MYH14 ENO1 ENO2 ENO3 PCMT1 | 5.99e-09 | 288 | 261 | 15 | 31501420 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | AAMP HK1 ACADSB EARS2 RSL1D1 ACTA1 INTS1 PSMB7 ACTC1 SPART PSMD2 NCBP1 MCM6 BIRC6 PARP1 DLD DYNC1H1 CARM1 TTF2 LARS1 MYO1B CBS SLC3A2 PPM1G EEF1A1 EEF1A1P5 RIF1 ATP1A1 ENO1 PCMT1 HDAC2 | 7.40e-09 | 1257 | 261 | 31 | 37317656 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | MYH9 MYH10 HSP90B2P DHX38 PSMD2 MCM6 EIPR1 BIRC6 PARP1 GCLC DYNC1H1 EEF1A1 TLN1 ATP1A1 UBASH3B ENO1 | 9.23e-09 | 344 | 261 | 16 | 30333137 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MYH9 MYH10 RSL1D1 DHX38 ACTA1 PSMD2 MCM6 ZNF217 CDCA2 PARP1 ZC3H11A SUPT6H NIP7 KNL1 ID1 MYO1B SLC3A2 PPM1G EEF1A1P5 KIF20A RIF1 ATP1A1 ENO1 PCCB SOAT1 PCMT1 HDAC2 | 9.24e-09 | 989 | 261 | 27 | 36424410 |
| Pubmed | MYH9 MYH10 HK1 ACTA1 PSMD2 MCM6 PARP1 DYNC1H1 PODXL LARS1 CBS EEF1A1 TLN1 ATP1A1 ENO1 ENO2 PCMT1 | 1.07e-08 | 397 | 261 | 17 | 21319273 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | MYH9 MYH10 RSL1D1 ACTA1 DYNC1H1 LARS1 MYO1B SLC3A2 EEF1A1 ATP1A1 | 2.28e-08 | 118 | 261 | 10 | 27377895 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | AAMP MYH9 MYH10 RSL1D1 DHX38 ACTC1 PSMD2 EXOSC8 NCBP1 TUBGCP2 LUZP1 TASOR2 PARP1 ZC3H11A NIP7 PKP1 DYNC1H1 DSG3 LARS1 MYO1B SPECC1L VIRMA MTPAP SLC3A2 PPM1G EEF1A1 PWP1 CCN1 ENO1 HSPA14 | 2.73e-08 | 1257 | 261 | 30 | 36526897 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MYH9 MYH10 PSMD2 MCM6 LUZP1 PARP1 SCN5A DYNC1H1 LARS1 MYO1B SPAG9 SPECC1L SLC3A2 EEF1A1 EEF1A1P5 TLN1 ATP1A1 ENO1 | 2.73e-08 | 477 | 261 | 18 | 31300519 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | KIF21B MYH9 MYH10 MYH11 HSP90B2P HK1 RSL1D1 PSMB7 ACTC1 MCM6 PARP1 SUPT6H DLD DYNC1H1 TTF2 LARS1 ATP6V1G1 PPM1G EEF1A1 MYH14 TLN1 ENO1 ENO2 HDAC2 | 3.23e-08 | 847 | 261 | 24 | 35235311 |
| Pubmed | 4.02e-08 | 67 | 261 | 8 | 29735542 | ||
| Pubmed | AAMP OBSCN NCBP1 MCM6 ITGA2 TTC3 ADD2 DMXL1 TASOR2 RNF214 EHMT2 RAD54B VPS13A USP35 HERC2 MED13 SLC37A3 PODXL TMEM54 WNT8B LAMA2 MYO1B SPECC1L RPUSD1 SLC3A2 CDH2 HSPA14 FBN3 HDAC2 | 4.73e-08 | 1215 | 261 | 29 | 15146197 | |
| Pubmed | DDAH2 MYH9 MYH10 MYH11 HSP90B2P HK1 ACTC1 PSMD2 DLD DYNC1H1 MYO1B SLC3A2 EEF1A1 MYH14 ATP1A1 CROCC ENO1 ENO2 ENO3 | 4.76e-08 | 552 | 261 | 19 | 36293380 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH9 INTS1 OBSCN NCBP1 DGKH BIRC6 MYO15B VPS13A PKHD1 DYNC1H1 CARM1 GALNTL6 ATG16L1 ZNF618 SPAG9 MTPAP EEF1A1 ARHGAP5 TLN1 CCDC87 FBN3 PCMT1 | 4.92e-08 | 736 | 261 | 22 | 29676528 |
| Pubmed | AAMP KIFBP MYH9 SPART PSMD2 EXOSC8 NCBP1 MCM6 DLD DYNC1H1 ABCC1 LARS1 ATP6V1G1 SPAG9 CBS SLC3A2 PPM1G EEF1A1 EEF1A1P5 TLN1 ATP1A1 ENO1 PCMT1 HDAC2 | 6.30e-08 | 878 | 261 | 24 | 37223481 | |
| Pubmed | KIFBP HK1 ACADSB EARS2 ATAD5 RSL1D1 SPART EXOSC8 TTC3 CEMIP2 ADD2 DMXL1 SH3BP4 PM20D2 PARP1 EHMT2 SUPT6H NIP7 VPS13A DLD HERC2 SLC30A9 NPAT GOPC NVL SLC3A2 PPM1G TLN1 CEP131 PEAK1 HSPA14 SOAT1 | 9.79e-08 | 1487 | 261 | 32 | 33957083 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | MYH9 MYH10 MYH11 MYO10 RSL1D1 ACTC1 PSMD2 PARP1 MYO15B DLD DYNC1H1 MYO1B SPECC1L SLC3A2 EEF1A1 MYH14 ATP1A1 ENO1 PCMT1 | 1.03e-07 | 580 | 261 | 19 | 35676659 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH9 MYH10 RSL1D1 DHX38 ACTA1 PSMD2 NCBP1 MCM6 BIRC6 PARP1 SUPT6H NIP7 PKP1 DYNC1H1 SPINK5 CARM1 NRDC LARS1 CBS SLC3A2 PPM1G EEF1A1 EEF1A1P5 PWP1 RIF1 TLN1 ATP1A1 ENO1 HSPA14 PCMT1 HDAC2 | 1.07e-07 | 1415 | 261 | 31 | 28515276 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | KIFBP MYH9 RSL1D1 CDCA2 SUPT6H NIP7 KNL1 DYRK1A MYO1B SPECC1L VIRMA PWP1 RIF1 PEAK1 HDAC2 | 1.18e-07 | 361 | 261 | 15 | 30344098 |
| Pubmed | AAMP CTU2 MYH9 MYH10 HK1 DHX38 SPART PSMD2 NCBP1 MCM6 PARP1 SUPT6H STK39 NRDC SLC3A2 PPM1G PWP1 RIF1 TLN1 MASP2 | 1.39e-07 | 653 | 261 | 20 | 33742100 | |
| Pubmed | TRIO MCAM ITGA2 CEMIP2 ADD2 GFOD2 PPP1R37 ABCC1 SASH1 GOPC SHB SLC3A2 ARHGAP5 PEAK1 ATP1A1 CDH2 | 1.49e-07 | 421 | 261 | 16 | 36976175 | |
| Pubmed | 1.62e-07 | 54 | 261 | 7 | 22266860 | ||
| Pubmed | MYH9 MYH10 HSP90B2P FRMPD4 TRIO PSMD2 BIRC6 GGT7 AMER2 PKP1 DLD ALDH6A1 STRN3 MAP2K4 GOPC KALRN NXPH1 ATP6V1G1 SLC3A2 PPM1G ELFN1 CEP131 PEAK1 CTNND2 ENO1 PCCB HDAC2 | 1.62e-07 | 1139 | 261 | 27 | 36417873 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | AAMP MYH9 MYH10 HK1 RSL1D1 SPART PSMD2 EXOSC8 NCBP1 MCM6 PARP1 ZC3H11A NFKBIE PKP1 DLD STK39 ALDH6A1 KNL1 PODXL ATP6V1G1 MUC5B TBL1XR1 SLC3A2 PPM1G EEF1A1 TLN1 LRP1 ATP1A1 ENO1 PCMT1 | 1.68e-07 | 1367 | 261 | 30 | 32687490 |
| Pubmed | TET2 ACTA1 INTS1 PSMD2 SUPT6H NFIL3 MED13 DYNC1H1 MYO1B EEF1A1 RIF1 ENO1 HDAC2 | 1.70e-07 | 272 | 261 | 13 | 31010829 | |
| Pubmed | Identification of FBXO25-interacting proteins using an integrated proteomics approach. | 1.84e-07 | 112 | 261 | 9 | 20473970 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH9 MYH10 HK1 RSL1D1 PSMB7 ACTC1 SPART PSMD2 EXOSC8 MCM6 LUZP1 ADD2 PARP1 HCFC2 DYNC1H1 STRN3 LARS1 MYO1B SPAG9 PPM1G EEF1A1 TLN1 ATP1A1 ENO1 ENO2 PCMT1 HDAC2 | 1.93e-07 | 1149 | 261 | 27 | 35446349 |
| Pubmed | Loss of cell adhesion causes hydrocephalus in nonmuscle myosin II-B-ablated and mutated mice. | 2.12e-07 | 8 | 261 | 4 | 17429076 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH9 MYH10 MYH11 HK1 PSMD2 NCBP1 CLSTN2 PARP1 DLD DYNC1H1 AFF2 LARS1 MYO1B MUC5B SLC3A2 EEF1A1 MYH14 TLN1 PEAK1 ATP1A1 ENO1 PCCB | 2.39e-07 | 807 | 261 | 22 | 30575818 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH9 MYH10 MYH11 FRMPD4 MYO10 RSL1D1 ACTA1 ACTC1 PSMD2 MCM6 LUZP1 PARP1 DYNC1H1 ADGRA3 LARS1 MYO1B SPECC1L SLC3A2 EEF1A1 EEF1A1P5 MYH14 ATP1A1 ENO1 PCMT1 | 2.60e-07 | 949 | 261 | 24 | 36574265 |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | MYH9 MYH10 ACADSB EARS2 PSMD2 MCM6 PARP1 DYNC1H1 LARS1 MYO1B SLC3A2 EEF1A1 MYH14 ATP1A1 ENO1 PCCB ENO3 FIGNL1 | 3.37e-07 | 565 | 261 | 18 | 33567341 |
| Pubmed | MYH9 MYH10 PSMD2 NCBP1 MCM6 GGT7 PARP1 STRN3 CBS SLC3A2 EEF1A1 EEF1A1P5 ATP1A1 ENO1 ENO2 ENO3 | 3.76e-07 | 451 | 261 | 16 | 36168627 | |
| Pubmed | Identification of the ligands of protein interaction domains through a functional approach. | 3.79e-07 | 9 | 261 | 4 | 17124247 | |
| Pubmed | 4.18e-07 | 3 | 261 | 3 | 20685736 | ||
| Pubmed | 4.18e-07 | 3 | 261 | 3 | 15177565 | ||
| Pubmed | Characterization of three full-length human nonmuscle myosin II paralogs. | 4.18e-07 | 3 | 261 | 3 | 24072716 | |
| Pubmed | 4.18e-07 | 3 | 261 | 3 | 15774463 | ||
| Pubmed | Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family. | 4.18e-07 | 3 | 261 | 3 | 14594953 | |
| Pubmed | 4.18e-07 | 3 | 261 | 3 | 15845534 | ||
| Pubmed | 4.88e-07 | 92 | 261 | 8 | 37343697 | ||
| Pubmed | Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly. | 5.31e-07 | 93 | 261 | 8 | 38245532 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | DHX38 ACTC1 SPART MCM6 SPDL1 CDCA2 PARP1 DYNC1H1 DYRK1A NVL EEF1A1 ATP1A1 ENO1 PCMT1 | 6.26e-07 | 357 | 261 | 14 | 37059091 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | MYH9 MCAM LUZP1 SPDL1 CDCA2 KIF15 DYNC1H1 KNL1 SLC3A2 KIF20A TLN1 ATP1A1 | 6.26e-07 | 256 | 261 | 12 | 33397691 |
| Pubmed | A point mutation in Myh10 causes major defects in heart development and body wall closure. | 6.28e-07 | 10 | 261 | 4 | 24825879 | |
| Pubmed | MYH10 MCAM SPART TTC3 PPP1R37 ERVV-1 HERC2 HERC1 DYNC1H1 KNL1 TTF2 EGLN2 SASH1 DOCK8 LAMA5 EEF1A1 ARHGAP5 LRP1 | 6.45e-07 | 591 | 261 | 18 | 15231748 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MYH9 MYH10 ATAD5 RSL1D1 DHX38 ACTA1 SPART PARP1 ZC3H11A DLD KNL1 TTF2 STRN3 LARS1 MYO1B SPAG9 CBS SLC3A2 RIF1 TLN1 ATP1A1 ENO1 PCMT1 | 7.37e-07 | 934 | 261 | 23 | 33916271 |
| Pubmed | MYH9 MYH10 MYO10 PSMB7 ACTC1 PSMD2 PARP1 DYNC1H1 GOPC LARS1 PPM1G EEF1A1P5 RIF1 TLN1 ENO1 ENO2 ENO3 | 8.05e-07 | 538 | 261 | 17 | 28524877 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | AAMP HK1 EXOSC8 NCBP1 MCM6 GCLC SUPT6H DYNC1H1 STRN3 DYRK1A SPAG9 CUBN PPM1G EEF1A1 ANKRD44 MYH14 ENO1 HSPA14 PCMT1 | 9.10e-07 | 670 | 261 | 19 | 22990118 |
| Pubmed | MYH9 MYH10 MYH11 ACTA1 DYNC1H1 ARAP1 EEF1A1 EEF1A1P5 MYH14 PEAK1 UBASH3B PCCB | 9.37e-07 | 266 | 261 | 12 | 19380743 | |
| Pubmed | MYH9 MYH10 HK1 RSL1D1 ACTA1 PSMD2 PARP1 DYNC1H1 CARM1 ABCC1 SLC3A2 EEF1A1 TLN1 ATP1A1 CDH2 PCCB | 9.51e-07 | 484 | 261 | 16 | 31995728 | |
| Pubmed | KIF21B MYH9 MYH10 MYO10 DHX38 INTS1 SREBF1 PSMD2 MCM6 ZNF217 EIPR1 BIRC6 RNF214 PARP1 ZC3H11A EHMT2 GCLC HCFC2 MED13 CARM1 EFL1 DYRK1A GRIK2 VIRMA OR56A4 ENO3 HSPA14 SOAT1 | 9.67e-07 | 1327 | 261 | 28 | 32694731 | |
| Pubmed | MYH9 MYH10 PSMD2 PARP1 DYNC1H1 GOPC LAMA5 SLC3A2 EEF1A1P5 CCN1 MYH14 TLN1 ATP1A1 ENO1 PCCB PCMT1 | 1.06e-06 | 488 | 261 | 16 | 31324722 | |
| Pubmed | 1.07e-06 | 45 | 261 | 6 | 22114352 | ||
| Pubmed | 1.09e-06 | 71 | 261 | 7 | 33541421 | ||
| Pubmed | TBL1Y ATAD5 DHX38 INTS1 EXOSC8 ZNF217 LUZP1 ZC3H11A EHMT2 SUPT6H NIP7 HCFC2 HERC2 MED13 STRN3 DYRK1A LAMA5 SPECC1L TBL1XR1 VIRMA MTPAP SLC3A2 EEF1A1P5 PWP1 RIF1 MICALL2 TLN1 CEP131 CTNND2 CROCC | 1.11e-06 | 1497 | 261 | 30 | 31527615 | |
| Pubmed | 1.46e-06 | 12 | 261 | 4 | 8424456 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MYH9 GALNT2 SREBF1 MCAM PSMD2 ITGA2 CEMIP2 DMXL1 GGT7 NEK4 ZC3H11A FBN1 RUSF1 ADGRA3 ABCC1 GOPC PODXL LAMA5 GRIK2 SLC3A2 CCN1 TLL1 LRP1 ATP1A1 CDH2 SOAT1 | 1.52e-06 | 1201 | 261 | 26 | 35696571 |
| Pubmed | 1.55e-06 | 144 | 261 | 9 | 35681168 | ||
| Pubmed | MYH11 HK1 ACADSB ACTA1 OBSCN DLD ALDH6A1 DYNC1H1 LAMA2 ATP1A1 ENO1 PCCB ENO3 | 1.56e-06 | 331 | 261 | 13 | 29199018 | |
| Pubmed | TET2 HDAC9 DCHS2 GALNT2 TRIO RSL1D1 PSMD2 NCBP1 TTC3 PARP1 FBN1 EHMT2 HERC2 MED13 DYNC1H1 EGLN2 KALRN LARS1 DYRK1A CBS EEF1A1 ARHGAP5 CCN1 MYH14 LRP1 CTNND2 PCCB | 1.66e-06 | 1285 | 261 | 27 | 35914814 | |
| Pubmed | 1.66e-06 | 4 | 261 | 3 | 11283949 | ||
| Pubmed | Modulation of embryonic and muscle-specific enolase gene products in the developing mouse hindlimb. | 1.66e-06 | 4 | 261 | 3 | 1280607 | |
| Pubmed | A Moonlighting Human Protein Is Involved in Mitochondrial Import of tRNA. | 1.66e-06 | 4 | 261 | 3 | 25918939 | |
| Pubmed | Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping. | 1.66e-06 | 4 | 261 | 3 | 18697221 | |
| Pubmed | MYH9 HK1 PSMB7 OBSCN ACTC1 PSMD2 PARP1 DYNC1H1 LARS1 MYO1B SPECC1L MYH14 HSPA14 | 1.72e-06 | 334 | 261 | 13 | 30425250 | |
| Pubmed | 1.74e-06 | 76 | 261 | 7 | 27542412 | ||
| Pubmed | 1.80e-06 | 49 | 261 | 6 | 21362503 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | KIFBP HK1 DHX38 EXOSC8 MCM6 BIRC6 EHMT2 NIP7 DYNC1H1 CARM1 TTF2 EFL1 LARS1 TBL1XR1 VIRMA CBS MTPAP ATP1A1 HSPA14 | 1.88e-06 | 704 | 261 | 19 | 29955894 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | DHX38 INTS1 ACTC1 PSMD2 CDCA2 PPP1R37 DLD HERC1 DYNC1H1 STRN3 MYO1B SPECC1L PPM1G ANKRD44 RIF1 PEAK1 PCMT1 | 1.89e-06 | 573 | 261 | 17 | 28330616 |
| Pubmed | 1.95e-06 | 28 | 261 | 5 | 30947518 | ||
| Pubmed | CTU2 MYH9 MYH10 GALNT2 TRIO EARS2 RSL1D1 SPART PSMD2 RETSAT BIRC6 LUZP1 PM20D2 PARP1 DYNC1H1 GOPC NRDC LARS1 LAMA5 MYO1B CBS MTPAP CCN1 ATP1A1 CROCC SOAT1 PCMT1 | 1.97e-06 | 1297 | 261 | 27 | 33545068 | |
| Pubmed | MYH9 MYH10 ACTC1 FBP2 PARP1 MYO1B SPECC1L SLC3A2 EEF1A1 MYH14 ATP1A1 ENO1 | 2.00e-06 | 286 | 261 | 12 | 32041737 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MYH10 AMER1 TRIO TUBGCP2 LUZP1 NFKBIE DLD HERC2 PPIP5K2 DYNC1H1 TTF2 STRN3 SHB DYRK1A MTPAP ARHGAP5 TLN1 ATP1A1 PCCB PDZRN3 PCMT1 | 2.28e-06 | 853 | 261 | 21 | 28718761 |
| Pubmed | 2.29e-06 | 51 | 261 | 6 | 11853319 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | KIFBP MYH10 HK3 TBL1Y MCM6 ZC3H11A NFIL3 PKP1 DYNC1H1 TTF2 GOPC LARS1 DYRK1A ID1 SPAG9 TBL1XR1 MTPAP RIF1 LRP1 HSPA14 HDAC2 | 2.46e-06 | 857 | 261 | 21 | 25609649 |
| Pubmed | MYH9 ATAD5 DHX38 INTS1 PSMB7 NCBP1 MCM6 PARP1 ZC3H11A EHMT2 SUPT6H MED13 CARM1 EFL1 CASP1 NVL TBL1XR1 VIRMA PPM1G EEF1A1 RIF1 PCMT1 HDAC2 | 2.93e-06 | 1014 | 261 | 23 | 32416067 | |
| Pubmed | MYH9 MYH10 AMER1 ACADSB PSMD2 NCBP1 MCM6 ZNF217 LUZP1 SH3BP4 PARP1 DLD MED13 DYNC1H1 LARS1 MYO1B SPECC1L TBL1XR1 MTPAP EEF1A1 CCN1 MYH14 TLN1 ATP1A1 ENO1 HDAC2 | 3.00e-06 | 1247 | 261 | 26 | 27684187 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | DDAH2 MYH9 FBP2 CEMIP2 SH3BP4 PKHD1 GATD1 DYNC1H1 KALRN DSG3 PODXL LAMA5 ATP6V1G1 MYO1B SPAG9 CUBN SLC3A2 EEF1A1 MYH14 TLN1 CROCC FIGNL1 MASP2 | 3.02e-06 | 1016 | 261 | 23 | 19056867 |
| Pubmed | MYH9 MYH10 TRIO DYNC1H1 PODXL LARS1 TBL1XR1 SLC3A2 EEF1A1 ATP1A1 ENO1 HDAC2 | 3.05e-06 | 298 | 261 | 12 | 30737378 | |
| Pubmed | MYH9 MYH10 RSL1D1 INTS1 PARP1 CD163L1 STRN3 MYO1B EEF1A1 ATP1A1 ENO1 ENO2 ENO3 HSPA14 | 3.25e-06 | 411 | 261 | 14 | 36652389 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYH9 MYH10 MYH11 TRIO HERC2 MYO1B SPECC1L EEF1A1 MYH14 ATP1A1 | 3.36e-06 | 202 | 261 | 10 | 33005030 |
| Pubmed | TET2 MYH9 ZNF217 BIRC6 LUZP1 SPDL1 KIF15 EHMT2 KNL1 NPAT LRP1 CEP131 PCCB HDAC2 | 3.95e-06 | 418 | 261 | 14 | 34709266 | |
| Pubmed | AMER1 ACADSB EARS2 SPART MCM6 TUBGCP2 VPS13A GATD1 HERC2 TTF2 DYRK1A MYO1B CBS MTPAP PPM1G RIF1 PCCB | 3.99e-06 | 606 | 261 | 17 | 36538041 | |
| Pubmed | Myosin II regulates extension, growth and patterning in the mammalian cochlear duct. | 4.13e-06 | 5 | 261 | 3 | 19439495 | |
| Pubmed | Telokin expression is restricted to smooth muscle tissues during mouse development. | 4.13e-06 | 5 | 261 | 3 | 11121372 | |
| Pubmed | 4.13e-06 | 5 | 261 | 3 | 33871354 | ||
| Interaction | PSMA1 interactions | MYH9 MYH10 PSMB7 PSMB10 PSMD2 NCBP1 MCM6 PTCH1 SH3BP4 PM20D2 NEK4 EHMT2 RAD54B ATG16L1 MYO1B SPAG9 VIRMA CBS AR PPM1G MYH14 ATP1A1 HDAC2 | 5.23e-08 | 480 | 255 | 23 | int:PSMA1 |
| Interaction | MYH10 interactions | TET2 MYH9 MYH10 MYH11 PSMB10 ACTC1 BIRC6 SPDL1 PARP1 HERC2 SPAG9 VIRMA AR EEF1A1P5 KIF20A MYH14 UBASH3B ENO1 HDAC2 | 1.74e-07 | 359 | 255 | 19 | int:MYH10 |
| Interaction | FLII interactions | CTU2 MYH9 MYH10 PSMB10 ACTC1 PARP1 HERC2 HERC1 CARM1 ATG16L1 LARS1 CASP1 SPAG9 VIRMA AR KIF20A HDAC2 | 2.76e-07 | 298 | 255 | 17 | int:FLII |
| Interaction | EED interactions | MYH9 MYH10 MYH11 TRIO RSL1D1 INTS1 OBSCN ACTC1 PSMD2 NCBP1 MCM6 TUBGCP2 BIRC6 DMXL1 TASOR2 SH3BP4 PARP1 ZC3H11A EHMT2 SUPT6H NIP7 HERC2 DYNC1H1 CARM1 LARS1 NVL LAMA5 MYO1B CUBN TBL1XR1 VIRMA AR EEF1A1 KIF20A RIF1 TLN1 ATP1A1 CROCC ENO1 PCCB SOAT1 HDAC2 | 3.45e-07 | 1445 | 255 | 42 | int:EED |
| Interaction | FGD5 interactions | MYH9 MYH10 MYH11 ACTA1 ACTC1 PSMD2 LUZP1 DYNC1H1 MYO1B SPECC1L EEF1A1 MYH14 ENO1 ENO2 | 4.19e-07 | 207 | 255 | 14 | int:FGD5 |
| Interaction | SIRT7 interactions | MYH9 MYH10 HK1 RSL1D1 DHX38 INTS1 PSMD2 NCBP1 MCM6 BIRC6 TASOR2 ZC3H11A SUPT6H DLD HERC2 DYNC1H1 NVL MYO1B SPAG9 VIRMA PPM1G PWP1 RIF1 MYH14 TLN1 ATP1A1 HDAC2 | 9.49e-07 | 744 | 255 | 27 | int:SIRT7 |
| Interaction | BRCA1 interactions | MYH9 MYH10 TRIO RSL1D1 DHX38 OBSCN PSMD2 EXOSC8 MCM6 LUZP1 CDCA2 PARP1 ZC3H11A SUPT6H HERC2 HERC1 TSGA10IP DYNC1H1 KNL1 REV1 CARM1 ABCC1 LARS1 DYRK1A SPAG9 CUBN TBL1XR1 AR KIF20A ANKRD44 RIF1 MYH14 TLN1 ENO1 HSPA14 PCMT1 HDAC2 | 1.22e-06 | 1249 | 255 | 37 | int:BRCA1 |
| Interaction | ITGB3 interactions | MYH9 MYH10 MYO10 DHX38 MCAM PSMD2 MCM6 BIRC6 PARP1 DYNC1H1 TLN1 ATP1A1 | 1.82e-06 | 170 | 255 | 12 | int:ITGB3 |
| Interaction | TSPY8 interactions | 2.00e-06 | 3 | 255 | 3 | int:TSPY8 | |
| Interaction | TET2 interactions | TET2 MYH9 MYH10 ACTA1 VIRMA AR EEF1A1 MYH14 ENO1 PCMT1 HDAC2 | 3.40e-06 | 150 | 255 | 11 | int:TET2 |
| Interaction | TPM1 interactions | TET2 MYH9 PSMB10 ACTC1 PSMD2 NOD2 DLD LARS1 DYRK1A SPAG9 CBS AR CROCC SOAT1 | 7.05e-06 | 263 | 255 | 14 | int:TPM1 |
| Interaction | RAB11A interactions | MYH9 MYH10 HK1 TRIO MCAM ITGA2 PTCH1 BIRC6 CEMIP2 DMXL1 NIP7 VPS13A PPP1R37 DLD CARM1 ABCC1 ATG16L1 GOPC PODXL SHB ATP6V1G1 VIRMA SLC3A2 LRP1 PEAK1 ATP1A1 SOAT1 | 7.29e-06 | 830 | 255 | 27 | int:RAB11A |
| Interaction | GAPDH interactions | TET2 MYH9 OBSCN ACTC1 NCBP1 SPDL1 CDCA2 PARP1 HERC2 KNL1 NPAT ATG16L1 VIRMA AR EEF1A1 RIF1 MICALL2 TLN1 ABCC12 CROCC ENO1 ENO2 ENO3 PCMT1 | 7.31e-06 | 686 | 255 | 24 | int:GAPDH |
| Interaction | CALD1 interactions | MYH9 ACTC1 LUZP1 PARP1 DLD DOCK8 DYRK1A MYO1B SPECC1L VIRMA LRP1 PEAK1 ATP1A1 FIGNL1 | 7.68e-06 | 265 | 255 | 14 | int:CALD1 |
| Interaction | CTNNA1 interactions | MCAM FBP2 NEK4 PARP1 DLD HERC2 CARM1 ATG16L1 SASH1 DYRK1A VIRMA AR EEF1A1 CEP131 PEAK1 CDH2 | 9.69e-06 | 347 | 255 | 16 | int:CTNNA1 |
| Interaction | ALB interactions | TET2 HDAC9 MYH9 ITGA2 SPDL1 SCN5A DYNC1H1 SPINK5 ATG16L1 LAMA5 ITLN2 CUBN VIRMA CRB1 KIF20A ENO1 HDAC2 | 1.10e-05 | 391 | 255 | 17 | int:ALB |
| Interaction | ACTR1A interactions | KIFBP MYH9 MYH10 ACADSB ACTC1 MCM6 NEK4 DLD DYNC1H1 DYRK1A SPAG9 VIRMA PRDM16 HDAC2 | 1.12e-05 | 274 | 255 | 14 | int:ACTR1A |
| Interaction | HDAC1 interactions | TET2 HDAC9 MYH9 MYH10 ACTA1 SREBF1 PSMD2 ZNF217 BIRC6 LUZP1 SPDL1 PARP1 KIF15 EHMT2 KNL1 NPAT ATG16L1 TMEM54 SPAG9 TBL1XR1 VIRMA AR KIF20A MYH14 TLN1 CEP131 UBASH3B CROCC ENO1 PCCB PRDM16 HDAC2 | 1.15e-05 | 1108 | 255 | 32 | int:HDAC1 |
| Interaction | SP1 interactions | MYH9 MYH10 MYH11 SREBF1 ACTC1 LUZP1 PARP1 FBN1 DYNC1H1 ATG16L1 MYO1B TBL1XR1 AR MYH14 TLN1 HDAC2 | 1.81e-05 | 365 | 255 | 16 | int:SP1 |
| Interaction | RGS12 interactions | 2.08e-05 | 45 | 255 | 6 | int:RGS12 | |
| Interaction | RNASEL interactions | 2.08e-05 | 45 | 255 | 6 | int:RNASEL | |
| Interaction | MYL9 interactions | 2.18e-05 | 67 | 255 | 7 | int:MYL9 | |
| Interaction | PHLPP1 interactions | MYH9 MCAM LUZP1 SPDL1 CDCA2 KIF15 DLD DYNC1H1 KNL1 VIRMA SLC3A2 KIF20A TLN1 ATP1A1 SOAT1 | 2.42e-05 | 333 | 255 | 15 | int:PHLPP1 |
| Interaction | PFN1 interactions | MYH9 TRIO ACTA1 ACTC1 BIRC6 PARP1 KIF15 DLD TTF2 ATG16L1 STRN3 DOCK8 VIRMA AR ARHGAP5 CEP131 PEAK1 ENO1 SOAT1 | 2.83e-05 | 509 | 255 | 19 | int:PFN1 |
| Interaction | U2AF2 interactions | MYH9 HK1 ACTA1 PSMB7 PSMD2 NCBP1 PARP1 HERC2 DYNC1H1 RUSF1 SPAG9 VIRMA AR ZNF835 SLC3A2 EEF1A1 EEF1A1P5 KIF20A ZNF526 MICALL2 TLN1 ATP1A1 | 3.02e-05 | 651 | 255 | 22 | int:U2AF2 |
| Interaction | H3C1 interactions | MYH9 MYH10 ATAD5 RSL1D1 DHX38 INTS1 PSMB7 MCM6 SPDL1 CDCA2 PARP1 EHMT2 NIP7 DYNC1H1 CARM1 DYRK1A LAMA2 SPAG9 VIRMA PPM1G PWP1 RIF1 MICALL2 MYH14 PRDM16 JHY HDAC2 | 3.11e-05 | 901 | 255 | 27 | int:H3C1 |
| Interaction | ENO1 interactions | TET2 DDAH2 MYH9 MYH10 MYH11 PSMD2 NEK4 VPS13A MED13 DYNC1H1 ATG16L1 GOPC SPECC1L VIRMA AR EEF1A1P5 MICALL2 MYH14 ENO1 ENO2 ENO3 PCMT1 HDAC2 | 3.14e-05 | 701 | 255 | 23 | int:ENO1 |
| Interaction | PPP1CB interactions | MYH9 ACTA1 INTS1 NCBP1 LUZP1 CDCA2 PARP1 PPP1R37 DYNC1H1 ATG16L1 MYO1B SPECC1L AR EEF1A1 KIF20A RIF1 MICALL2 PRDM16 | 3.21e-05 | 469 | 255 | 18 | int:PPP1CB |
| Interaction | CLTC interactions | TET2 MYH9 DHX38 ACTA1 PSMB7 ACTC1 SPART PTCH1 SPDL1 NEK4 HERC2 HERC1 ATG16L1 LARS1 DYRK1A VIRMA AR KIF20A TLN1 ATP1A1 PRDM16 SOAT1 | 3.31e-05 | 655 | 255 | 22 | int:CLTC |
| Interaction | TCP1 interactions | TBL1Y ACTC1 PSMD2 EIPR1 SPDL1 SH3BP4 NOD2 NEK4 EHMT2 HCFC2 ATG16L1 STRN3 EFL1 PNPLA5 VIRMA AR TLN1 ATP1A1 UBASH3B HDAC2 | 3.33e-05 | 561 | 255 | 20 | int:TCP1 |
| Interaction | CTNNB1 interactions | MYH9 MYH10 AMER1 MCAM PARP1 ZC3H11A HERC2 SLC30A9 DYNC1H1 CARM1 ABCC1 STRN3 LARS1 MYO1B GRIK2 SPECC1L TBL1XR1 VIRMA AR KIF20A ARHGAP5 MYH14 TLN1 ABCC12 ATP1A1 CTNND2 CROCC CDH2 HDAC2 | 3.34e-05 | 1009 | 255 | 29 | int:CTNNB1 |
| Interaction | SMARCC1 interactions | MYH9 MYH10 SREBF1 ACTC1 PARP1 PPIP5K2 UFSP1 CARM1 ATG16L1 SPAG9 TBL1XR1 VIRMA AR SLC3A2 EEF1A1P5 HDAC2 | 3.35e-05 | 384 | 255 | 16 | int:SMARCC1 |
| Interaction | CCDC8 interactions | GALNT2 INTS1 ACTC1 PSMD2 MCM6 PARP1 PKP1 HERC2 DYNC1H1 SLC37A3 GOPC LARS1 DYRK1A MYO1B SPECC1L SLC3A2 EEF1A1 MYH14 CEP131 ATP1A1 ENO1 HDAC2 | 3.38e-05 | 656 | 255 | 22 | int:CCDC8 |
| Interaction | MYL12A interactions | TET2 MYH9 MYH10 MYH11 PSMB7 ACTC1 NEK4 HERC1 DYRK1A VIRMA MYH14 | 3.50e-05 | 192 | 255 | 11 | int:MYL12A |
| Interaction | RUVBL1 interactions | MYH9 MYH10 ACTC1 PSMD2 NCBP1 NEK4 EHMT2 SUPT6H DLD ATG16L1 DOCK8 SPAG9 VIRMA AR EEF1A1 KIF20A MYH14 CCDC87 ATP1A1 HDAC2 | 4.70e-05 | 575 | 255 | 20 | int:RUVBL1 |
| Interaction | KIF23 interactions | MYH9 MYH10 MYH11 RSL1D1 DHX38 ACTA1 ACTC1 PSMD2 NCBP1 BIRC6 ADD2 PARP1 NIP7 DYNC1H1 LARS1 DYRK1A NVL LAMA2 MYO1B SPAG9 PNPLA5 VIRMA CBS SLC3A2 EEF1A1P5 KIF20A MYH14 ENO1 PCMT1 | 4.92e-05 | 1031 | 255 | 29 | int:KIF23 |
| Interaction | ARHGAP24 interactions | MYH9 MYH10 PSMD2 NCBP1 MCM6 GGT7 PARP1 DLD STRN3 CBS SLC3A2 EEF1A1 EEF1A1P5 ATP1A1 ENO1 ENO2 ENO3 PCMT1 | 5.09e-05 | 486 | 255 | 18 | int:ARHGAP24 |
| Interaction | DUSP16 interactions | AMER1 EIPR1 TTC3 LUZP1 TASOR2 NYNRIN PPIP5K2 DYNC1H1 KNL1 VIRMA FIGNL1 PDZRN3 | 5.21e-05 | 237 | 255 | 12 | int:DUSP16 |
| Interaction | TP53BP1 interactions | AAMP DHX38 ACTC1 PSMD2 MCM6 SPDL1 PARP1 HERC2 MED13 ARAP1 CARM1 FMO1 SPAG9 VIRMA PPM1G RIF1 ATP1A1 ENO1 PCMT1 | 5.26e-05 | 533 | 255 | 19 | int:TP53BP1 |
| Interaction | TRIM37 interactions | MYH9 MYH10 ACTA1 ACTC1 ZNF217 RHPN1 PARP1 ZC3H11A FBN1 ATG16L1 MYO1B VIRMA EEF1A1 KIF20A CCN1 MYH14 LRP1 CEP131 ENO1 PCCB PCMT1 | 5.59e-05 | 630 | 255 | 21 | int:TRIM37 |
| Interaction | MYH11 interactions | 5.98e-05 | 136 | 255 | 9 | int:MYH11 | |
| Interaction | CDK2 interactions | MYH9 MYH10 HK1 ACTA1 PSMD2 MCM6 LUZP1 PARP1 SCN5A DYNC1H1 NPAT EGLN2 PODXL TMEM54 LARS1 MYO1B SPECC1L CBS EEF1A1 TLN1 ATP1A1 ENO1 ENO2 PCMT1 | 6.17e-05 | 783 | 255 | 24 | int:CDK2 |
| Interaction | ISG15 interactions | MYH9 MYH10 GALNT2 RSL1D1 ACTA1 PSMB7 ACTC1 PSMD2 LUZP1 PARP1 DYNC1H1 LARS1 DYRK1A MYO1B SPECC1L SLC3A2 ATP1A1 ENO1 | 6.28e-05 | 494 | 255 | 18 | int:ISG15 |
| Interaction | RCOR1 interactions | MYH9 MYH10 ZNF217 EIPR1 BIRC6 LUZP1 SPDL1 EHMT2 KNL1 NPAT SPAG9 TBL1XR1 VIRMA AR CEP131 PCCB PRDM16 HDAC2 | 6.28e-05 | 494 | 255 | 18 | int:RCOR1 |
| Interaction | LRRC31 interactions | MYH9 MYH10 MYH11 TRIO PARP1 HERC2 MYO1B SPECC1L EEF1A1 MYH14 ATP1A1 | 6.35e-05 | 205 | 255 | 11 | int:LRRC31 |
| Interaction | ENO3 interactions | 6.52e-05 | 107 | 255 | 8 | int:ENO3 | |
| Interaction | SMC3 interactions | HDAC9 MYH11 INTS1 MCM6 NEK4 DLD HERC2 DYNC1H1 PLIN4 ATG16L1 SPAG9 VIRMA AR EEF1A1 ENO1 HDAC2 | 6.88e-05 | 408 | 255 | 16 | int:SMC3 |
| Interaction | ATOH1 interactions | 6.92e-05 | 80 | 255 | 7 | int:ATOH1 | |
| Interaction | USP15 interactions | MYH9 MYH10 PSMB7 PSMD2 MCM6 PTCH1 SPDL1 RHPN1 PARP1 KIF15 HERC1 DYNC1H1 STRN3 ID1 SPAG9 VIRMA EEF1A1 ENO1 HDAC2 | 7.24e-05 | 546 | 255 | 19 | int:USP15 |
| Interaction | CIT interactions | KIFBP MYH9 MYH10 MYH11 HSP90B2P RSL1D1 DHX38 INTS1 ACTC1 PSMD2 NCBP1 TTC3 BIRC6 LUZP1 SUPT6H NIP7 HERC1 DYNC1H1 CARM1 KALRN DYRK1A NVL MYO1B SPECC1L PNPLA5 VIRMA SLC3A2 EEF1A1P5 KIF20A PWP1 RIF1 MYH14 ELFN1 ATP1A1 PCMT1 HDAC2 | 7.89e-05 | 1450 | 255 | 36 | int:CIT |
| Interaction | MYH9 interactions | TET2 MYH9 MYH10 MYH11 ACTA1 PSMB7 PSMB10 ACTC1 PSMD2 LUZP1 SPDL1 NEK4 MYO1B SPAG9 SPECC1L VIRMA KIF20A MYH14 TLN1 ATP1A1 UBASH3B ENO1 HDAC2 | 9.48e-05 | 754 | 255 | 23 | int:MYH9 |
| Interaction | GAPVD1 interactions | 1.03e-04 | 180 | 255 | 10 | int:GAPVD1 | |
| Interaction | MYL6 interactions | TET2 MYH9 MYH10 MYH11 ACTC1 PTCH1 NEK4 ATG16L1 VIRMA AR KIF20A MYH14 | 1.05e-04 | 255 | 255 | 12 | int:MYL6 |
| Interaction | SNAI3 interactions | 1.07e-04 | 8 | 255 | 3 | int:SNAI3 | |
| Interaction | TRIM28 interactions | KIFBP AMER1 HK1 ZNF274 RSL1D1 DHX38 ACTC1 EXOSC8 NCBP1 MCM6 ZNF621 PTCH1 BIRC6 SPDL1 NEK4 PARP1 EHMT2 NIP7 ZNF620 DLD DYNC1H1 CARM1 TTF2 ATG16L1 EFL1 LARS1 CASP1 TBL1XR1 VIRMA CBS MTPAP AR PPM1G EEF1A1P5 ATP1A1 HSPA14 | 1.10e-04 | 1474 | 255 | 36 | int:TRIM28 |
| Interaction | ACTB interactions | TET2 MYH9 MYH10 MYH11 MYO10 ACTA1 PSMB10 ACTC1 NCBP1 TUBGCP2 LUZP1 ADD2 SPDL1 NEK4 PARP1 VPS13A DYNC1H1 CARM1 TTF2 PODXL MYO1B TBL1XR1 VIRMA AR EEF1A1 MICALL2 PEAK1 UBASH3B HDAC2 | 1.17e-04 | 1083 | 255 | 29 | int:ACTB |
| Interaction | RUVBL2 interactions | MYH9 SREBF1 ACTC1 NCBP1 NEK4 PARP1 EHMT2 SUPT6H DLD DYNC1H1 ATG16L1 STRN3 LARS1 SPAG9 VIRMA AR EEF1A1 KIF20A CCDC87 HDAC2 | 1.20e-04 | 616 | 255 | 20 | int:RUVBL2 |
| Interaction | DDX39B interactions | MYH9 MYH10 DHX38 SREBF1 ACTC1 NCBP1 LUZP1 ZC3H11A PKP1 DLD HERC2 DYNC1H1 ATG16L1 MYO1B SPECC1L VIRMA KIF20A MYH14 ENO1 | 1.27e-04 | 570 | 255 | 19 | int:DDX39B |
| Interaction | NELFA interactions | 1.27e-04 | 88 | 255 | 7 | int:NELFA | |
| Interaction | USP48 interactions | DDAH2 MYH9 MYH10 MYH11 HK1 ACTC1 PSMD2 PARP1 DLD DYNC1H1 MYO1B AR SLC3A2 EEF1A1 RIF1 MYH14 ATP1A1 CROCC ENO1 ENO2 ENO3 | 1.27e-04 | 668 | 255 | 21 | int:USP48 |
| Interaction | PPP2R2A interactions | MYH9 PSMD2 NOD2 PARP1 ATG16L1 STRN3 GOPC NRDC SPAG9 VIRMA AR PWP1 HDAC2 | 1.29e-04 | 301 | 255 | 13 | int:PPP2R2A |
| Interaction | SQSTM1 interactions | AMER1 ZNF274 TRIO EARS2 SPART PSMD2 TUBGCP2 LUZP1 NOD2 RNF214 PARP1 NYNRIN NLRC5 ULK4 PLIN1 DYNC1H1 UFSP1 CARM1 TTF2 ATG16L1 SHB CASP1 DYRK1A ID1 MYO1B VIRMA AR KIF20A PWP1 CEP131 ATP1A1 CROCC | 1.30e-04 | 1257 | 255 | 32 | int:SQSTM1 |
| Interaction | XRCC6 interactions | MYH9 MYH10 ACADSB DHX38 INTS1 SPDL1 CDCA2 NEK4 PARP1 ZC3H11A DLD USP35 ARAP1 ATG16L1 DYRK1A NVL VIRMA AR PPM1G EEF1A1P5 KIF20A ARHGAP5 RIF1 ATP1A1 ENO1 PRDM16 | 1.31e-04 | 928 | 255 | 26 | int:XRCC6 |
| Interaction | ESRRB interactions | HK1 ATAD5 INTS1 EHMT2 MED13 SLC3A2 EEF1A1 EEF1A1P5 RIF1 ATP1A1 UBASH3B HDAC2 | 1.35e-04 | 262 | 255 | 12 | int:ESRRB |
| Interaction | CAV1 interactions | HK1 TRIO MCAM ITGA2 PTCH1 CEMIP2 ADD2 SH3BP4 ABCC1 ATG16L1 SLC37A3 GOPC SHB ID1 VIRMA AR SLC3A2 PPM1G KIF20A LRP1 PEAK1 ATP1A1 | 1.42e-04 | 724 | 255 | 22 | int:CAV1 |
| Interaction | PSMD2 interactions | MYH9 PSMB7 PSMD2 EIPR1 PTCH1 PARP1 DLD HERC2 ABCC1 ATG16L1 SPAG9 VIRMA AR PPM1G ATP1A1 ENO1 | 1.44e-04 | 435 | 255 | 16 | int:PSMD2 |
| Interaction | PSMD5 interactions | 1.46e-04 | 120 | 255 | 8 | int:PSMD5 | |
| Interaction | TFCP2 interactions | MYH9 MYH10 MYH11 ACTA1 ACTC1 PARP1 DLD DYNC1H1 MYO1B EEF1A1 MYH14 ENO1 ENO2 ENO3 PCMT1 HDAC2 | 1.48e-04 | 436 | 255 | 16 | int:TFCP2 |
| Interaction | CALM1 interactions | MYH9 MYO10 OBSCN ACTC1 PSMD2 ADD2 DMXL1 MYO3A SCN5A VPS13A HERC2 CNGA2 STRN3 SHB MYO1B MTPAP AR KIF20A PEAK1 ENO1 | 1.49e-04 | 626 | 255 | 20 | int:CALM1 |
| Interaction | MYH14 interactions | 1.53e-04 | 189 | 255 | 10 | int:MYH14 | |
| Interaction | SIRT6 interactions | RSL1D1 DHX38 PSMD2 MCM6 TASOR2 CDCA2 PARP1 EHMT2 SUPT6H NIP7 HERC2 DYRK1A NVL TBL1XR1 EEF1A1 KIF20A PWP1 MYH14 CEP131 HDAC2 | 1.55e-04 | 628 | 255 | 20 | int:SIRT6 |
| Interaction | FBXW7 interactions | MYH9 MYH10 RSL1D1 SREBF1 MCM6 FBP2 LUZP1 SPDL1 RNF214 EHMT2 SUPT6H NIP7 PKP1 HERC2 MED13 DYNC1H1 CARM1 EGLN2 GOPC LARS1 DYRK1A NVL MYO1B SPECC1L VIRMA RSPRY1 EEF1A1 PWP1 MYH14 ENO1 HDAC2 | 1.60e-04 | 1215 | 255 | 31 | int:FBXW7 |
| Interaction | SPAG9 interactions | MYH9 MYH10 PSMB7 PSMD2 NCBP1 MCM6 MAP2K4 PODXL SPAG9 VIRMA KIF20A HDAC2 | 1.67e-04 | 268 | 255 | 12 | int:SPAG9 |
| Interaction | KIF20A interactions | MYH9 MYH10 MYH11 RSL1D1 ACTC1 NCBP1 TUBGCP2 LUZP1 PARP1 SUPT6H NIP7 HERC2 HERC1 DYRK1A NVL MYO1B SPAG9 SPECC1L PNPLA5 VIRMA EEF1A1P5 KIF20A CCN1 MYH14 ELFN1 UBASH3B PCMT1 HDAC2 | 1.70e-04 | 1052 | 255 | 28 | int:KIF20A |
| Interaction | RHOQ interactions | RSL1D1 MCAM ITGA2 CEMIP2 ADD2 DMXL1 SH3BP4 GFOD2 VPS13A ABCC1 GOPC DOCK8 SLC3A2 ARHGAP5 PEAK1 ATP1A1 | 1.73e-04 | 442 | 255 | 16 | int:RHOQ |
| Interaction | KCTD13 interactions | MYH9 MYH10 MYH11 HK1 TRIO ACTA1 PSMD2 ITGA2 LUZP1 ADD2 PARP1 DLD DYNC1H1 STRN3 MAP2K4 GOPC NRDC KALRN DOCK8 LARS1 DYRK1A SPECC1L VIRMA SLC3A2 EEF1A1 ARHGAP5 MYH14 TLN1 PEAK1 ATP1A1 CTNND2 CROCC CDH2 ENO2 | 1.78e-04 | 1394 | 255 | 34 | int:KCTD13 |
| Interaction | MYO6 interactions | MYH9 ACTA1 MCAM ACTC1 SH3BP4 NEK4 MYO3A STRN3 DOCK8 LARS1 VIRMA AR KIF20A CEP131 ENO1 | 1.79e-04 | 398 | 255 | 15 | int:MYO6 |
| Interaction | APC2 interactions | 1.83e-04 | 23 | 255 | 4 | int:APC2 | |
| Interaction | MYCBP2 interactions | KIF21B MYO10 CLSTN2 PARP1 HERC2 DYNC1H1 CARM1 ATG16L1 ZNF618 DYRK1A SPECC1L VIRMA AR HDAC2 | 1.84e-04 | 355 | 255 | 14 | int:MYCBP2 |
| Interaction | AFF1 interactions | 1.86e-04 | 66 | 255 | 6 | int:AFF1 | |
| Interaction | ACTN4 interactions | MYH9 ACTA1 ACTC1 NCBP1 NEK4 DLD ATG16L1 MYO1B SPECC1L VIRMA AR KIF20A MICALL2 UBASH3B HDAC2 | 1.89e-04 | 400 | 255 | 15 | int:ACTN4 |
| Interaction | LGALS9 interactions | MYH9 MYH10 HK1 RSL1D1 ACTA1 PSMD2 PARP1 DYNC1H1 CARM1 ABCC1 ATG16L1 PODXL SLC3A2 EEF1A1 TLN1 LRP1 ATP1A1 CDH2 PCCB | 1.89e-04 | 588 | 255 | 19 | int:LGALS9 |
| Interaction | KIF15 interactions | 1.92e-04 | 94 | 255 | 7 | int:KIF15 | |
| Interaction | ZDHHC15 interactions | 1.94e-04 | 125 | 255 | 8 | int:ZDHHC15 | |
| Interaction | STIP1 interactions | MYH10 PSMD2 NCBP1 MCM6 TUBGCP2 PARP1 SUPT6H DLD DYNC1H1 NPAT CARM1 DOCK8 LARS1 SPAG9 PNPLA5 VIRMA CBS AR SLC3A2 RIF1 TLN1 ATP1A1 ENO1 ENO2 ENO3 HSPA14 HDAC2 | 1.95e-04 | 1006 | 255 | 27 | int:STIP1 |
| Interaction | VDAC1 interactions | MYH11 HK1 GALNT2 RSL1D1 MCAM ABCC1 ATG16L1 LARS1 VIRMA AR RSPRY1 SLC3A2 EEF1A1 KIF20A RIF1 GPCPD1 ATP1A1 SOAT1 | 2.00e-04 | 542 | 255 | 18 | int:VDAC1 |
| Interaction | CASZ1 interactions | 2.03e-04 | 43 | 255 | 5 | int:CASZ1 | |
| Interaction | HDAC4 interactions | HDAC9 TRIO RSL1D1 CARMIL3 ACTA1 PSMD2 DMXL1 PARP1 FCHSD2 NFKBIE DLD HERC2 KALRN NVL GRIK2 TBL1XR1 VIRMA AR PPM1G EEF1A1 ARHGAP5 ENO1 | 2.09e-04 | 744 | 255 | 22 | int:HDAC4 |
| Interaction | OBSL1 interactions | RSL1D1 ACTA1 PSMB7 PSMB10 ACTC1 PSMD2 NCBP1 MCM6 TASOR2 PARP1 ZC3H11A SUPT6H HERC2 DYNC1H1 DYRK1A LAMA5 MTPAP AR EEF1A1 PWP1 RIF1 TLN1 ENO1 PCMT1 HDAC2 | 2.09e-04 | 902 | 255 | 25 | int:OBSL1 |
| Interaction | PSMD6 interactions | MYH9 PSMB7 PSMB10 PSMD2 PTCH1 DLD DYNC1H1 CARM1 LARS1 SPAG9 VIRMA AR EEF1A1 | 2.14e-04 | 317 | 255 | 13 | int:PSMD6 |
| Interaction | FBXO25 interactions | 2.23e-04 | 198 | 255 | 10 | int:FBXO25 | |
| Interaction | HSP90AB1 interactions | TET2 MYH9 MCM6 TUBGCP2 SPDL1 NOD2 NEK4 PARP1 FCHSD2 VPS13A REV1 CARM1 TTF2 ATG16L1 LARS1 ATP6V1G1 PNPLA5 VIRMA AR KIF20A TLN1 UNC13C PEAK1 UBASH3B ENO1 HDAC2 | 2.24e-04 | 960 | 255 | 26 | int:HSP90AB1 |
| Interaction | TOP3B interactions | MYH10 TRIO MYO10 INTS1 SREBF1 OBSCN PSMB10 EXOSC8 PTCH1 TTC3 BIRC6 SH3BP4 GGT7 NOD2 RHPN1 ZC3H11A SCN5A NLRC5 ULK4 HERC2 HERC1 MED13 DYNC1H1 ARAP1 SLC37A3 KALRN LARS1 DYRK1A LAMA5 MYO1B MROH6 ADAMTS7 TLN1 CEP131 PRDM16 | 2.25e-04 | 1470 | 255 | 35 | int:TOP3B |
| Interaction | ACTR2 interactions | KIFBP MYH9 MYO10 ACTA1 PSMB10 ACTC1 LUZP1 PARP1 EFL1 VIRMA AR ENO1 PRDM16 | 2.56e-04 | 323 | 255 | 13 | int:ACTR2 |
| Interaction | COPA interactions | DHX38 SPART MCM6 ZNF217 SPDL1 DLD HERC2 PPIP5K2 ATG16L1 VIRMA PPM1G KIF20A ATP1A1 PRDM16 HDAC2 | 2.59e-04 | 412 | 255 | 15 | int:COPA |
| Interaction | HDAC2 interactions | TET2 HDAC9 MYH9 MYH10 TRIO ZNF217 PARP1 EHMT2 HERC2 DYNC1H1 ATG16L1 PODXL LARS1 SPAG9 TBL1XR1 VIRMA AR SLC3A2 EEF1A1 KIF20A ATP1A1 ENO1 PRDM16 HDAC2 | 2.77e-04 | 865 | 255 | 24 | int:HDAC2 |
| Interaction | TPX2 interactions | 2.84e-04 | 204 | 255 | 10 | int:TPX2 | |
| Interaction | HSF1 interactions | AAMP ACTA1 PSMD2 NCBP1 MCM6 PARP1 ZC3H11A SUPT6H PKP1 GOPC LARS1 SPAG9 CBS EEF1A1 ATP1A1 ENO1 ENO2 PDZRN3 HDAC2 | 2.93e-04 | 609 | 255 | 19 | int:HSF1 |
| Interaction | MED6 interactions | 2.99e-04 | 101 | 255 | 7 | int:MED6 | |
| Interaction | C9orf72 interactions | AAMP HK1 ACADSB EARS2 RSL1D1 ACTA1 INTS1 PSMB7 ACTC1 SPART PSMD2 NCBP1 MCM6 BIRC6 PARP1 DLD DYNC1H1 CARM1 TTF2 ATG16L1 LARS1 MYO1B CBS SLC3A2 PPM1G EEF1A1 EEF1A1P5 RIF1 ATP1A1 ENO1 PCMT1 HDAC2 | 3.07e-04 | 1319 | 255 | 32 | int:C9orf72 |
| Cytoband | Yp11.2 | 7.37e-08 | 94 | 262 | 8 | Yp11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYp11 | 2.64e-06 | 150 | 262 | 8 | chrYp11 | |
| Cytoband | 7q32-q33 | 3.24e-05 | 2 | 262 | 2 | 7q32-q33 | |
| Cytoband | 1q41-q42 | 3.21e-04 | 5 | 262 | 2 | 1q41-q42 | |
| GeneFamily | Myosin heavy chains | 7.85e-06 | 15 | 162 | 4 | 1098 | |
| GeneFamily | WD repeat domain containing | KIF21B AAMP TBL1Y EIPR1 DMXL1 HERC1 ATG16L1 STRN3 WDR31 TBL1XR1 PWP1 | 2.49e-05 | 262 | 162 | 11 | 362 |
| GeneFamily | Perilipins | 7.84e-04 | 5 | 162 | 2 | 678 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.04e-03 | 50 | 162 | 4 | 1293 | |
| GeneFamily | Actins | 1.17e-03 | 6 | 162 | 2 | 929 | |
| GeneFamily | AAA ATPases | 1.29e-03 | 53 | 162 | 4 | 413 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TRIO MYO10 SPART TOGARAM1 NEK4 FCHSD2 VPS13A STK39 PPIP5K2 MED13 ADGRA3 NPAT ABCC1 STRN3 MAP2K4 SASH1 PODXL SHB DYRK1A NVL ID1 MYO1B SPAG9 SPECC1L RIF1 CCN1 CDH2 PCMT1 | 2.61e-08 | 856 | 256 | 28 | M4500 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | KIF21B TET2 MYO10 BIRC6 FCHSD2 KIF15 HERC1 MED13 SLC37A3 DOCK8 RIF1 TLN1 | 2.27e-07 | 180 | 256 | 12 | M8239 |
| Coexpression | MOOTHA_GLYCOLYSIS | 1.53e-06 | 21 | 256 | 5 | M16111 | |
| Coexpression | BENPORATH_SOX2_TARGETS | HDAC9 KIFBP DHX38 PGM2L1 NCBP1 ZNF217 KIF15 RAD54B NIP7 TTF2 SASH1 ID1 ATP6V1G1 SPAG9 TBL1XR1 SLC3A2 PWP1 RIF1 CCN1 CEP131 CDH2 HDAC2 | 3.64e-06 | 734 | 256 | 22 | M3835 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TRIO MYO10 FCHSD2 VPS13A STK39 MED13 STRN3 MAP2K4 SHB DYRK1A NVL ID1 MYO1B SPECC1L CCN1 PCMT1 | 1.58e-05 | 466 | 256 | 16 | M13522 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | MYH9 TBL1Y AKR1D1 ADD2 FCHSD2 MED13 ABCC1 DSG3 NVL ODC1 PEAK1 UBASH3B | 1.66e-05 | 272 | 256 | 12 | MM1027 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | ACADSB ATAD5 MCAM NCBP1 MCM6 CEMIP2 SH3BP4 NOD2 FBN1 KIF15 RAD54B HERC2 KNL1 TTF2 PODXL LARS1 DYRK1A ID1 ATP6V1G1 SPAG9 KIF20A UBASH3B SOAT1 | 2.46e-05 | 892 | 256 | 23 | M18120 |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_UP | 2.94e-05 | 200 | 256 | 10 | M9470 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 2.94e-05 | 200 | 256 | 10 | M387 | |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 6.46e-05 | 177 | 256 | 9 | M9401 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | MYH9 AKR1D1 ADD2 FCHSD2 MED13 ABCC1 DSG3 NVL ODC1 PEAK1 UBASH3B | 6.47e-05 | 265 | 256 | 11 | M1684 |
| Coexpression | HOSHIDA_LIVER_CANCER_SURVIVAL_UP | 8.06e-05 | 73 | 256 | 6 | M6939 | |
| Coexpression | GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_UP | 8.35e-05 | 183 | 256 | 9 | M7631 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_UP | 9.07e-05 | 185 | 256 | 9 | M374 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 1.06e-04 | 110 | 256 | 7 | M1309 | |
| Coexpression | BENPORATH_NANOG_TARGETS | DHX38 SPART ZNF217 EIPR1 DMXL1 MYO3A KIF15 RAD54B NIP7 TTF2 SASH1 PODXL LARS1 NVL ID1 ATP6V1G1 SPAG9 TBL1XR1 RSPRY1 PWP1 RIF1 CCN1 CDH2 | 1.15e-04 | 988 | 256 | 23 | M6616 |
| Coexpression | ZHOU_TNF_SIGNALING_4HR | 1.26e-04 | 50 | 256 | 5 | M1520 | |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | MYH10 HK1 ATAD5 PSMB7 SREBF1 SPART PSMD2 EXOSC8 MCM6 ADD2 SPDL1 CDCA2 GFOD2 GCLC ZNF620 DLD PPIP5K2 SLC30A9 CARM1 LARS1 PPM1G KIF20A RIF1 MICALL2 PCCB PCMT1 HDAC2 | 1.34e-04 | 1271 | 256 | 27 | M39197 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | HDAC9 ATAD5 NCBP1 MCM6 TUBGCP2 TTC3 SPDL1 CDCA2 RAD54B PPIP5K2 KNL1 NPAT REV1 KIF20A RIF1 CTNND2 CDH2 FIGNL1 | 1.39e-04 | 680 | 256 | 18 | MM456 |
| Coexpression | GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP | 1.46e-04 | 197 | 256 | 9 | M9725 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 1.58e-04 | 199 | 256 | 9 | M7259 | |
| Coexpression | GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_DN | 1.58e-04 | 199 | 256 | 9 | M7782 | |
| Coexpression | GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN | 1.58e-04 | 199 | 256 | 9 | M4248 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 1.64e-04 | 200 | 256 | 9 | M301 | |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_DN | 1.64e-04 | 200 | 256 | 9 | M9779 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN | 1.64e-04 | 200 | 256 | 9 | M7744 | |
| Coexpression | NGUYEN_NOTCH1_TARGETS_DN | 1.65e-04 | 83 | 256 | 6 | M14650 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#1_top-relative-expression-ranked_1000 | HDAC9 AMER1 ATAD5 TOGARAM1 PTCH1 TASOR2 CDCA2 NEK4 HCFC2 SLC37A3 GOPC TBL1XR1 ANKRD44 TLL1 CDH2 FIGNL1 PDZRN3 | 1.03e-06 | 349 | 252 | 17 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k1_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | FAM185A ATAD5 RSL1D1 PGM2L1 MDGA2 CLSTN2 PTCH1 CEMIP2 SPDL1 GGT7 CDCA2 NEK4 RHPN1 RNF214 KIF15 RAD54B VPS13A HERC1 KNL1 PODXL ZNF618 ARHGAP5 RIF1 MYH14 TLL1 CTNND2 CDH2 PRDM16 FIGNL1 XKR5 | 9.63e-06 | 1060 | 252 | 30 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | MYH11 FRMPD4 MYO10 OBSCN MCAM MDGA2 DGKH MYO3A AFF2 LAMA2 MYO1B | 1.67e-08 | 189 | 261 | 11 | d7ed96add29f219183c802895fbff519b627f635 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-08 | 160 | 261 | 10 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-08 | 160 | 261 | 10 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | KIF21B SPDL1 CDCA2 KIF15 CD163L1 RAD54B PLIN1 KNL1 GOPC CROCC | 5.78e-08 | 167 | 261 | 10 | 754e6412d3b9cc0b126e59593df2f5956b4712ef |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | HDAC9 ACTA1 OBSCN ACTC1 SCN5A ALPK3 LAMA2 CTNND2 CDH2 PDZRN3 | 1.23e-07 | 181 | 261 | 10 | 719eb532453ab7cd7893726885bc75d74a10b21e |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | HDAC9 ACTA1 OBSCN ACTC1 SCN5A ALPK3 LAMA2 CTNND2 CDH2 PDZRN3 | 1.51e-07 | 185 | 261 | 10 | 549eeb521c3985bff396ea0f202db21822efa51f |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.67e-07 | 187 | 261 | 10 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | DGKH BIRC6 CEMIP2 TASOR2 HERC1 MED13 DYNC1H1 DYRK1A ANKRD44 GPCPD1 | 1.75e-07 | 188 | 261 | 10 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 1.75e-07 | 188 | 261 | 10 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | MYH9 COL6A5 CLSTN2 PTCH1 BMP5 FBN1 MYO1B ADAMTS7 LRP1 CTNND2 | 2.83e-07 | 198 | 261 | 10 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYH10 MYO10 COL6A5 PTCH1 BMP5 FBN1 SPECC1L LRP1 PEAK1 PDZRN3 | 2.97e-07 | 199 | 261 | 10 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | MYH10 MYO10 COL6A5 PTCH1 CEMIP2 BMP5 FBN1 MICALL2 LRP1 PDZRN3 | 3.11e-07 | 200 | 261 | 10 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 7.96e-07 | 171 | 261 | 9 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.01e-06 | 176 | 261 | 9 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 177 | 261 | 9 | 2433924dcb085ebbe2545d476ebd7ee68e6092fb | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-06 | 177 | 261 | 9 | 2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 182 | 261 | 9 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 183 | 261 | 9 | 769a022fe8568ec49e66f792cc5777e713a7571c | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-06 | 183 | 261 | 9 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 183 | 261 | 9 | aac0695fafa59cabd920ee18b1139d3e00d898e8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 184 | 261 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 184 | 261 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 184 | 261 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.46e-06 | 184 | 261 | 9 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.53e-06 | 185 | 261 | 9 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 187 | 261 | 9 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 187 | 261 | 9 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-06 | 189 | 261 | 9 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.91e-06 | 190 | 261 | 9 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-06 | 191 | 261 | 9 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 191 | 261 | 9 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.36e-06 | 195 | 261 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-06 | 195 | 261 | 9 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | (01)_IL1RL1+-(1)_GFP|(01)_IL1RL1+ / shred by cell type by condition | 2.46e-06 | 196 | 261 | 9 | b598b1112242534e139318012b257ed3cb09da83 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.79e-06 | 199 | 261 | 9 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.79e-06 | 199 | 261 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 261 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 261 | 9 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.03e-06 | 165 | 261 | 8 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.19e-06 | 169 | 261 | 8 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.51e-06 | 170 | 261 | 8 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.75e-06 | 122 | 261 | 7 | a4220adb4e6055a599bd9bbf65d460fc4e68b543 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.18e-06 | 172 | 261 | 8 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.28e-06 | 175 | 261 | 8 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.28e-06 | 175 | 261 | 8 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.28e-06 | 175 | 261 | 8 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.67e-06 | 176 | 261 | 8 | a84361308e5e96f3a30246cd29e109c321ee65bf | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.67e-06 | 176 | 261 | 8 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.67e-06 | 176 | 261 | 8 | d70fdc7bc48719776ed1e7c01118385e3a21623f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 177 | 261 | 8 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-05 | 178 | 261 | 8 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 178 | 261 | 8 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 179 | 261 | 8 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 1.12e-05 | 129 | 261 | 7 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-05 | 180 | 261 | 8 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 181 | 261 | 8 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 181 | 261 | 8 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.23e-05 | 182 | 261 | 8 | db5d6c5e7d59734653906b126f2c1d57461a5290 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.34e-05 | 184 | 261 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | P28-Endothelial|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.34e-05 | 184 | 261 | 8 | b056411f499866097f4322999cfd1e57a3927b78 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.39e-05 | 185 | 261 | 8 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-05 | 185 | 261 | 8 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-05 | 185 | 261 | 8 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 134 | 261 | 7 | d101e16cb87ff72c81324406fe7e3d70ed8f45df | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 134 | 261 | 7 | 0c63c8b3c748d29c59fcb27d03276ba4f6a0d6b2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 187 | 261 | 8 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.50e-05 | 187 | 261 | 8 | a3592f056e1c2f82ba325fea2ecc4dd6c6347c81 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.50e-05 | 187 | 261 | 8 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.50e-05 | 187 | 261 | 8 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 187 | 261 | 8 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 187 | 261 | 8 | 52ffd4be374e329ac8d321063f061b826d252956 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.56e-05 | 188 | 261 | 8 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.56e-05 | 188 | 261 | 8 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 189 | 261 | 8 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 189 | 261 | 8 | 25db316f66cee53774bb2b286cc457b37353356c | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 189 | 261 | 8 | 8a38baee58a27c2fa3f4bd131ab9f15723ed9295 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 190 | 261 | 8 | e64b191f928935484e2c993d7f8af0572a617a3a | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.75e-05 | 191 | 261 | 8 | ddbc5f97f2aef19be4ad93db4139876c939b848e | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-05 | 191 | 261 | 8 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-05 | 191 | 261 | 8 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.75e-05 | 191 | 261 | 8 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.82e-05 | 192 | 261 | 8 | 2802fae55683345ff94a1ecf73b6fbee4f17481e | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 192 | 261 | 8 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.82e-05 | 192 | 261 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.89e-05 | 193 | 261 | 8 | a332dfdcc48c405020014e644aa4d14fda98cc86 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-05 | 193 | 261 | 8 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.89e-05 | 193 | 261 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.89e-05 | 193 | 261 | 8 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.96e-05 | 194 | 261 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.96e-05 | 194 | 261 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.03e-05 | 195 | 261 | 8 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-05 | 195 | 261 | 8 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-05 | 195 | 261 | 8 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.03e-05 | 195 | 261 | 8 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 195 | 261 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.03e-05 | 195 | 261 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.11e-05 | 196 | 261 | 8 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|COVID-19_Mild / Disease condition and Cell class | 2.11e-05 | 196 | 261 | 8 | f245e929a286cb097130572e1027b4f01be8b04d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.18e-05 | 197 | 261 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Healthy-T/NK_proliferative|World / disease group, cell group and cell class | 2.18e-05 | 197 | 261 | 8 | e90be1e7e02f736b6aab14010a912b592d6f1e80 | |
| Drug | B0683 | MYH9 MYH10 MYH11 MYO10 ACTA1 ACTC1 ITGA2 MYO3A DSG3 MYO1B MYH14 | 7.58e-08 | 117 | 252 | 11 | CID006398969 |
| Drug | dimidium | 2.16e-07 | 6 | 252 | 4 | CID000068207 | |
| Drug | purealin | 2.40e-07 | 58 | 252 | 8 | CID006419303 | |
| Drug | o-succinylbenzoic acid | 1.22e-06 | 18 | 252 | 5 | CID000000955 | |
| Drug | AC1L1A7Z | 1.22e-06 | 18 | 252 | 5 | CID000000874 | |
| Drug | N-succinylphenylglycine | 1.34e-06 | 3 | 252 | 3 | CID000448582 | |
| Drug | AC1MOUJL | 1.34e-06 | 3 | 252 | 3 | CID003400924 | |
| Drug | C03356 | 1.34e-06 | 3 | 252 | 3 | CID000439988 | |
| Drug | 3-bromo-2-(bromomethyl)propionic acid | 1.34e-06 | 3 | 252 | 3 | CID000318915 | |
| Drug | C04309 | 1.34e-06 | 3 | 252 | 3 | CID000440293 | |
| Drug | 2,3-diketo-1-phosphohexane | 1.34e-06 | 3 | 252 | 3 | CID000192519 | |
| Drug | formycin triphosphate | 1.43e-06 | 51 | 252 | 7 | CID000122274 | |
| Drug | 3-phosphoglycerate | 5.10e-06 | 114 | 252 | 9 | CID000000724 | |
| Drug | dimethyl chlorophosphate | 5.32e-06 | 4 | 252 | 3 | CID000101863 | |
| Drug | [2-(oxidoamino)-2-oxoethyl]phosphonic acid | 5.32e-06 | 4 | 252 | 3 | CID011969443 | |
| Drug | 3-aminoenolpyruvate-2-phosphate | 5.32e-06 | 4 | 252 | 3 | CID003037152 | |
| Drug | 2-ptz | 5.32e-06 | 4 | 252 | 3 | CID000445375 | |
| Drug | tricyclohexylammonium | 5.32e-06 | 4 | 252 | 3 | CID000226271 | |
| Drug | Methamphetamine | HDAC9 KIFBP SLC29A3 HK1 OBSCN MCAM ACTC1 DGKH ADD2 PARP1 ZC3H11A KIF15 EHMT2 SUPT6H NFIL3 SCN5A DLD HERC2 PPIP5K2 CCDC116 GALNTL6 PODXL ID1 SPAG9 CUBN AR KIF20A ANKRD44 CCN1 LRP1 ATP1A1 ENO1 PRDM16 ENO2 PCMT1 | 5.54e-06 | 1401 | 252 | 35 | ctd:D008694 |
| Drug | blebbistatin | 5.88e-06 | 116 | 252 | 9 | CID003476986 | |
| Drug | maltos | HK1 PGM2L1 MCM6 DLD TMEM54 LAMA2 LAMA5 ITLN2 ODC1 CBS SLC3A2 TIRAP ENO1 PRDM16 ENO2 ENO3 | 8.81e-06 | 393 | 252 | 16 | CID000000294 |
| Drug | AC1Q6RZ4 | 9.50e-06 | 123 | 252 | 9 | CID000000719 | |
| Drug | N-methylacrylamide | 1.32e-05 | 5 | 252 | 3 | CID000014471 | |
| Drug | AC1L1CAI | 1.32e-05 | 5 | 252 | 3 | CID000000145 | |
| Drug | tartronate semialdehyde phosphate | 1.32e-05 | 5 | 252 | 3 | CID000151938 | |
| Drug | 2-phospho-3-butenoic acid | 1.32e-05 | 5 | 252 | 3 | CID000191423 | |
| Drug | 1-Pdmsp | 1.32e-05 | 5 | 252 | 3 | CID000000561 | |
| Drug | oxaloacetate | 1.38e-05 | 198 | 252 | 11 | CID000000970 | |
| Drug | N-ethylmaleimide | MYH9 MYH10 MYH11 MYO10 ACTA1 PSMB10 ACTC1 PSMD2 PARP1 MYO3A KIF15 DLD CASP1 MYO1B SLC3A2 EEF1A1 KIF20A MYH14 | 1.73e-05 | 511 | 252 | 18 | CID000004362 |
| Drug | Z(2-Cl)-OSu | 2.61e-05 | 6 | 252 | 3 | CID000580665 | |
| Drug | 4-(N,N-dimethylamino)cinnamoyl-CoA | 2.61e-05 | 6 | 252 | 3 | CID000445461 | |
| Drug | 3-methylcyclohexanol | 2.61e-05 | 6 | 252 | 3 | CID000011566 | |
| Drug | troglitazone | FRMPD4 MYO10 AKR1D1 SREBF1 MCM6 CLSTN2 FBP2 ITGA2 RETSAT NOD2 PARP1 ZC3H11A FBN1 KIF15 GCLC NFIL3 CREB3L3 PLIN1 PLIN4 TTF2 FMO1 PODXL TMEM54 ID1 ODC1 CBS AR SLC3A2 KIF20A CCN1 ENO1 SOAT1 | 3.00e-05 | 1329 | 252 | 32 | ctd:C057693 |
| Drug | AC1L1IZ2 | MYH9 MYH10 MYH11 HK1 MYO10 ACTA1 ACTC1 PSMD2 MYO3A DYNC1H1 ID1 MYO1B MYH14 | 3.73e-05 | 304 | 252 | 13 | CID000004795 |
| Drug | polymer | 3.97e-05 | 18 | 252 | 4 | CID003032581 | |
| Drug | NSC611747 | MYH10 MYH11 MYO10 ACTA1 ACTC1 MYO3A STK39 PLIN1 MAP2K4 GOPC CASP1 MYO1B ODC1 PPM1G | 4.16e-05 | 352 | 252 | 14 | CID000002534 |
| Drug | N-tert-butylacrylamide | 4.54e-05 | 7 | 252 | 3 | CID000007877 | |
| Drug | glycidol phosphate | 4.54e-05 | 7 | 252 | 3 | CID000152659 | |
| Drug | lavendustin C6 | 4.54e-05 | 7 | 252 | 3 | CID000126839 | |
| Drug | CPEP | 4.54e-05 | 7 | 252 | 3 | CID000360637 | |
| Drug | PPCM | 4.78e-05 | 59 | 252 | 6 | CID000001292 | |
| Drug | purpurin-18 | 4.98e-05 | 19 | 252 | 4 | CID005489047 | |
| Drug | AC1L2YVP | 4.98e-05 | 19 | 252 | 4 | CID000080135 | |
| Drug | LG 5 | 5.26e-05 | 60 | 252 | 6 | CID011840957 | |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 5.62e-05 | 191 | 252 | 10 | 993_UP | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | GALNT2 TRIO TUBGCP2 NYNRIN VPS13A PPP1R37 ATG16L1 CASP1 JHY HDAC2 | 6.68e-05 | 195 | 252 | 10 | 2308_DN |
| Drug | Nortriptyline hydrochloride [894-71-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A | ACADSB MYO10 PSMB10 ANKMY1 TUBGCP2 NIP7 ALDH6A1 SPINK5 ATG16L1 STRN3 | 6.97e-05 | 196 | 252 | 10 | 6003_DN |
| Drug | 5-propyl-dUrd | 7.20e-05 | 8 | 252 | 3 | CID000160155 | |
| Drug | tetrahydropyran-2-methanol | 7.20e-05 | 8 | 252 | 3 | CID000007524 | |
| Drug | macrophomate | 7.20e-05 | 8 | 252 | 3 | CID010889109 | |
| Drug | 1,3-dibromopropane | 7.20e-05 | 8 | 252 | 3 | CID000008001 | |
| Drug | 2-phosphoglycerate | 8.45e-05 | 94 | 252 | 7 | CID000000059 | |
| Drug | Mercuric Chloride | SLC29A3 ACTA1 PSMB7 PSMD2 NCBP1 TUBGCP2 PTCH1 RETSAT PM20D2 CDCA2 PARP1 AMER2 GCLC CREB3L3 ALDH6A1 DYNC1H1 ABCC1 STRN3 DOCK8 CASP1 VIRMA MTPAP SLC3A2 ATP1A1 CROCC ENO1 CDH2 MASP2 | 8.70e-05 | 1155 | 252 | 28 | ctd:D008627 |
| Drug | AC1LADJ6 | 1.02e-04 | 130 | 252 | 8 | CID000486032 | |
| Drug | nitazoxanide | 1.07e-04 | 9 | 252 | 3 | ctd:C041747 | |
| Drug | bromochloromethane | 1.07e-04 | 9 | 252 | 3 | CID000006333 | |
| Drug | AC1L19IJ | 1.07e-04 | 9 | 252 | 3 | CID000000562 | |
| Drug | C 6H | 1.07e-04 | 9 | 252 | 3 | CID000094022 | |
| Drug | AC1L1A4W | 1.07e-04 | 9 | 252 | 3 | CID000000837 | |
| Drug | thioglycerol | 1.09e-04 | 43 | 252 | 5 | CID000007291 | |
| Drug | 1,3-dithiolane-2-thione | 1.22e-04 | 2 | 252 | 2 | CID000013196 | |
| Drug | buthionine sulfoximine ethyl ester | 1.22e-04 | 2 | 252 | 2 | ctd:C065566 | |
| Drug | DEAPA | 1.22e-04 | 2 | 252 | 2 | CID000061011 | |
| Drug | TBECH | 1.22e-04 | 2 | 252 | 2 | CID000018728 | |
| Drug | DMAPA | 1.22e-04 | 2 | 252 | 2 | CID000135080 | |
| Drug | CMNU | 1.22e-04 | 2 | 252 | 2 | CID000043256 | |
| Drug | Brn 0611686 | 1.22e-04 | 2 | 252 | 2 | CID000080163 | |
| Drug | cyclopentane carboxamide | 1.22e-04 | 2 | 252 | 2 | CID000226274 | |
| Drug | trifluoromethanol | 1.22e-04 | 2 | 252 | 2 | CID000073894 | |
| Drug | phosphoenolpyruvate | 1.23e-04 | 210 | 252 | 10 | CID000001005 | |
| Drug | S-(-)-Etomoxir | 1.25e-04 | 100 | 252 | 7 | CID000060765 | |
| Drug | AC1MNW2N | 1.26e-04 | 70 | 252 | 6 | CID003359490 | |
| Drug | muraglitazar | AKR1D1 SREBF1 CLSTN2 FBP2 ITGA2 RETSAT NOD2 CREB3L3 ALDH6A1 PLIN4 FMO1 ID1 CBS LRP1 FIGNL1 | 1.39e-04 | 444 | 252 | 15 | ctd:C500085 |
| Drug | neotrehalose | 1.44e-04 | 214 | 252 | 10 | CID000001143 | |
| Drug | sodium antimony | 1.52e-04 | 10 | 252 | 3 | CID000025469 | |
| Drug | pyrene-4,5-dione | 1.52e-04 | 10 | 252 | 3 | CID000160814 | |
| Drug | 2-ethylhydracrylic acid | 1.52e-04 | 10 | 252 | 3 | CID000188979 | |
| Drug | L-fuconic acid | 1.52e-04 | 10 | 252 | 3 | CID000345732 | |
| Drug | phosphoenolthiopyruvate | 1.52e-04 | 10 | 252 | 3 | CID000194910 | |
| Drug | xylonate | 1.52e-04 | 10 | 252 | 3 | CID000010264 | |
| Drug | diallyl | 1.54e-04 | 25 | 252 | 4 | CID000011598 | |
| Drug | NSC107658 | MYH9 SLC29A3 MYH10 MYH11 HK1 HK3 MYO10 ACTA1 ACTC1 MYO3A MYO1B MYH14 | 1.67e-04 | 306 | 252 | 12 | CID000002919 |
| Drug | Epirubicin | 1.68e-04 | 47 | 252 | 5 | ctd:D015251 | |
| Drug | AC1Q6RZL | 1.68e-04 | 47 | 252 | 5 | CID000001144 | |
| Drug | MgCl2 | MYH9 MYH10 MYH11 HK1 HK3 EARS2 MYO10 ACTA1 ACTC1 MYO3A MYO1B EEF1A1 MYH14 | 1.72e-04 | 354 | 252 | 13 | CID000024584 |
| Disease | Malignant neoplasm of breast | CTU2 MYH9 HK3 OBSCN TTC3 PARP1 ZC3H11A NIP7 NLRC5 HERC2 CNGA2 RUSF1 ABCC1 MAP2K4 KALRN LAMA2 GRIK2 CUBN AR RIF1 TLL1 ENO1 CDH2 FLACC1 HSPA14 | 4.43e-06 | 1074 | 247 | 25 | C0006142 |
| Disease | aortic measurement | HDAC9 MYH10 MDGA2 FBN1 ULK4 MAP2K4 SASH1 KALRN ADAMTS7 TLL1 LRP1 | 9.70e-06 | 251 | 247 | 11 | EFO_0020865 |
| Disease | epilepsy (implicated_via_orthology) | 1.02e-05 | 163 | 247 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | response to serotonin-norephinephrine reuptake inhibitor | 1.20e-05 | 36 | 247 | 5 | EFO_0006325 | |
| Disease | Colorectal Carcinoma | TET2 HK3 OBSCN CLSTN2 ZNF217 PARP1 AMER2 VPS13A PKHD1 ABCC1 KALRN WNT8B AKAP3 MYO1B ODC1 CUBN LRP1 CTNND2 | 2.95e-05 | 702 | 247 | 18 | C0009402 |
| Disease | melanoma | 5.00e-05 | 248 | 247 | 10 | C0025202 | |
| Disease | Malformations of Cortical Development, Group II | 6.98e-05 | 2 | 247 | 2 | C1837249 | |
| Disease | Enzymopathy | 9.10e-05 | 11 | 247 | 3 | C0520572 | |
| Disease | complement factor H-related protein 1 measurement | 1.06e-04 | 56 | 247 | 5 | EFO_0600054 | |
| Disease | Intellectual Disability | KIFBP HK1 FRMPD4 TRIO PARP1 MED13 DYNC1H1 DOCK8 SPECC1L ODC1 ZNF526 ATP1A1 CDH2 | 1.12e-04 | 447 | 247 | 13 | C3714756 |
| Disease | idiopathic pulmonary fibrosis | 1.16e-04 | 57 | 247 | 5 | EFO_0000768 | |
| Disease | basophil measurement | 1.48e-04 | 60 | 247 | 5 | EFO_0803539 | |
| Disease | connective tissue disease (implicated_via_orthology) | 2.08e-04 | 3 | 247 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | rectum cancer, colonic neoplasm | 2.08e-04 | 3 | 247 | 2 | EFO_0004288, EFO_1000657 | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 2.08e-04 | 3 | 247 | 2 | DOID:0080463 (implicated_via_orthology) | |
| Disease | sensory system disease (implicated_via_orthology) | 2.08e-04 | 3 | 247 | 2 | DOID:0050155 (implicated_via_orthology) | |
| Disease | neutrophil percentage of leukocytes | TET2 HDAC9 HSP90B2P ATAD5 PSMD2 MCM6 DGKH FBN1 NLRC5 KALRN DOCK8 UBASH3B ENO1 FLACC1 XKR5 | 2.15e-04 | 610 | 247 | 15 | EFO_0007990 |
| Disease | Proteinuria | 2.45e-04 | 15 | 247 | 3 | HP_0000093 | |
| Disease | hemorrhoid | 2.49e-04 | 147 | 247 | 7 | EFO_0009552 | |
| Disease | nucleotide measurement | 3.73e-04 | 73 | 247 | 5 | EFO_0010513 | |
| Disease | platelet crit | TET2 HDAC9 CTU2 HK1 GALNT2 PSMB7 MCAM SH3BP4 PARP1 NPAT KALRN LAMA5 CUBN EEF1A1P5 TLN1 UBASH3B ENO1 PRDM16 FLACC1 | 4.55e-04 | 952 | 247 | 19 | EFO_0007985 |
| Disease | Alopecia | 5.08e-04 | 19 | 247 | 3 | C0002170 | |
| Disease | Atrial septal defect | 6.86e-04 | 5 | 247 | 2 | cv:C0018817 | |
| Disease | spine bone mineral density change measurement, response to combination chemotherapy | 6.86e-04 | 5 | 247 | 2 | EFO_0007965, EFO_0008474 | |
| Disease | descending aortic diameter | 8.79e-04 | 88 | 247 | 5 | EFO_0021788 | |
| Disease | Global developmental delay | 9.16e-04 | 133 | 247 | 6 | C0557874 | |
| Disease | nevus count, cutaneous melanoma | 1.02e-03 | 91 | 247 | 5 | EFO_0000389, EFO_0004632 | |
| Disease | thoracic aortic aneurysm, Abdominal Aortic Aneurysm, brain aneurysm | 1.02e-03 | 6 | 247 | 2 | EFO_0003870, EFO_0004214, EFO_0004282 | |
| Disease | mean platelet volume | TET2 HDAC9 MYH9 MYH11 GALNT2 ATAD5 PSMD2 ANKMY1 ZNF217 ITGA2 ARAP1 STRN3 NRDC KALRN DOCK8 DYRK1A EEF1A1P5 UBASH3B PRDM16 | 1.03e-03 | 1020 | 247 | 19 | EFO_0004584 |
| Disease | Metastatic melanoma | 1.09e-03 | 54 | 247 | 4 | C0278883 | |
| Disease | facial height measurement | 1.28e-03 | 142 | 247 | 6 | EFO_0007856 | |
| Disease | free androgen index | 1.30e-03 | 374 | 247 | 10 | EFO_0007005 | |
| Disease | myeloperoxidase measurement | 1.31e-03 | 26 | 247 | 3 | EFO_0005243 | |
| Disease | Hypertrophic Cardiomyopathy | 1.34e-03 | 57 | 247 | 4 | C0007194 | |
| Disease | Abnormality of the eye | 1.43e-03 | 7 | 247 | 2 | C4316870 | |
| Disease | coronary artery disease (is_implicated_in) | 1.56e-03 | 100 | 247 | 5 | DOID:3393 (is_implicated_in) | |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.89e-03 | 8 | 247 | 2 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.89e-03 | 8 | 247 | 2 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.89e-03 | 8 | 247 | 2 | DOID:0081112 (implicated_via_orthology) | |
| Disease | autoimmune disease (is_implicated_in) | 1.89e-03 | 8 | 247 | 2 | DOID:417 (is_implicated_in) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.89e-03 | 8 | 247 | 2 | DOID:14004 (implicated_via_orthology) | |
| Disease | creatinine measurement | KIF21B TET2 OBSCN PSMD2 DGKH BIRC6 GGT7 PKHD1 PLIN4 LAMA2 LAMA5 ATP6V1G1 CUBN AR PPM1G MICALL2 CCN1 ADAMTS7 | 1.92e-03 | 995 | 247 | 18 | EFO_0004518 |
| Disease | Ulcerative Colitis | 1.94e-03 | 63 | 247 | 4 | C0009324 | |
| Disease | Breast Carcinoma | CTU2 MYH9 PARP1 ZC3H11A HERC2 ABCC1 MAP2K4 GRIK2 AR ENO1 CDH2 FLACC1 | 2.07e-03 | 538 | 247 | 12 | C0678222 |
| Disease | response to bronchodilator, FEV/FEC ratio | TET2 MDGA2 CLSTN2 PARP1 PKHD1 ULK4 GALNTL6 KALRN NXPH1 GRIK2 PNPLA5 ADAMTS7 UBASH3B CDH2 PRDM16 | 2.15e-03 | 766 | 247 | 15 | EFO_0004713, GO_0097366 |
| Disease | blood viscosity | 2.19e-03 | 31 | 247 | 3 | EFO_0004301 | |
| Disease | obesity (implicated_via_orthology) | 2.32e-03 | 215 | 247 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | Lymphoma, Non-Hodgkin | 2.40e-03 | 32 | 247 | 3 | C0024305 | |
| Disease | Acute Confusional Migraine | 2.42e-03 | 9 | 247 | 2 | C0521664 | |
| Disease | Status Migrainosus | 2.42e-03 | 9 | 247 | 2 | C0338489 | |
| Disease | Abdominal Migraine | 2.42e-03 | 9 | 247 | 2 | C0270858 | |
| Disease | Sick Headaches | 2.42e-03 | 9 | 247 | 2 | C0700438 | |
| Disease | Cervical Migraine Syndrome | 2.42e-03 | 9 | 247 | 2 | C0007852 | |
| Disease | Ostium secundum atrial septal defect | 2.42e-03 | 9 | 247 | 2 | C0344724 | |
| Disease | Prostatic Cancer, Castration-Resistant | 2.42e-03 | 9 | 247 | 2 | C3658266 | |
| Disease | Prostatic Neoplasms, Castration-Resistant | 2.42e-03 | 9 | 247 | 2 | C3658267 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 2.42e-03 | 9 | 247 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | Hemicrania migraine | 2.42e-03 | 9 | 247 | 2 | C0018984 | |
| Disease | lifestyle measurement, systolic blood pressure | 2.42e-03 | 9 | 247 | 2 | EFO_0006335, EFO_0010724 | |
| Disease | myeloid white cell count | TET2 HDAC9 HSP90B2P PSMB7 SREBF1 PSMD2 MCM6 DGKH NLRC5 FMO1 DOCK8 DYRK1A MYO1B CBS ATP1A1 UBASH3B ENO1 | 2.47e-03 | 937 | 247 | 17 | EFO_0007988 |
| Disease | sensorineural hearing loss (is_implicated_in) | 2.63e-03 | 33 | 247 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | coronary artery disease | TET2 HDAC9 KIFBP MYH11 GALNT2 DHX38 SREBF1 DMXL1 GGT7 PARP1 ZC3H11A PKHD1 DOCK8 SPECC1L ADAMTS7 ELFN1 LRP1 UBASH3B PCCB PRDM16 | 2.67e-03 | 1194 | 247 | 20 | EFO_0001645 |
| Disease | alopecia areata (is_marker_for) | 3.00e-03 | 10 | 247 | 2 | DOID:986 (is_marker_for) | |
| Disease | 1,7-dimethylurate measurement | 3.00e-03 | 10 | 247 | 2 | EFO_0021512 | |
| Disease | aortic aneurysm | 3.00e-03 | 10 | 247 | 2 | EFO_0001666 | |
| Disease | intestinal atresia (implicated_via_orthology) | 3.00e-03 | 10 | 247 | 2 | DOID:10486 (implicated_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.00e-03 | 10 | 247 | 2 | cv:C4707243 | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 3.00e-03 | 10 | 247 | 2 | DOID:13832 (implicated_via_orthology) | |
| Disease | PR interval | HDAC9 MYH11 OBSCN MYO3A SCN5A ALPK3 HCFC2 KALRN NXPH1 CTNND2 PDZRN3 | 3.22e-03 | 495 | 247 | 11 | EFO_0004462 |
| Disease | electroencephalogram measurement | 3.49e-03 | 74 | 247 | 4 | EFO_0004357 | |
| Disease | eye measurement, sun exposure measurement | 3.65e-03 | 11 | 247 | 2 | EFO_0004731, EFO_0010729 | |
| Disease | GM3 ganglioside measurement | 3.65e-03 | 11 | 247 | 2 | EFO_0021451 | |
| Disease | Hyperhomocysteinemia | 3.65e-03 | 11 | 247 | 2 | C0598608 | |
| Disease | pulmonary fibrosis | 3.65e-03 | 11 | 247 | 2 | EFO_0009448 | |
| Disease | Marfan Syndrome | 3.65e-03 | 11 | 247 | 2 | C0024796 | |
| Disease | Myocardial Ischemia | 3.76e-03 | 176 | 247 | 6 | C0151744 | |
| Disease | hyperhomocysteinemia (biomarker_via_orthology) | 4.36e-03 | 12 | 247 | 2 | DOID:9279 (biomarker_via_orthology) | |
| Disease | rotator cuff tear | 4.36e-03 | 12 | 247 | 2 | EFO_1001250 | |
| Disease | mosaic loss of chromosome Y measurement | 4.61e-03 | 80 | 247 | 4 | EFO_0007783 | |
| Disease | asthma | HDAC9 HSP90B2P CLSTN2 ZNF217 NRROS PTCH1 NOD2 MAP2K4 TBL1XR1 CRB1 LRP1 UNC13C CTNND2 PRDM16 | 4.61e-03 | 751 | 247 | 14 | MONDO_0004979 |
| Disease | cortical surface area measurement | TET2 HDAC9 DDAH2 DCHS2 MYH10 SREBF1 PTCH1 RETSAT LUZP1 FBN1 PKHD1 USP35 STRN3 PODXL LAMA2 ADAMTS7 TLL1 PDZRN3 FBN3 SOAT1 PCMT1 | 4.74e-03 | 1345 | 247 | 21 | EFO_0010736 |
| Disease | obsolete_red blood cell distribution width | HK1 GALNT2 PSMB7 MCM6 ZNF217 BIRC6 CDCA2 ZC3H11A VPS13A STK39 HERC1 ALDH6A1 KNL1 ABCC1 KALRN DOCK8 NVL TBL1XR1 EEF1A1 EEF1A1P5 ENO3 | 4.82e-03 | 1347 | 247 | 21 | EFO_0005192 |
| Disease | Amino Acid Metabolism, Inherited Disorders | 5.12e-03 | 13 | 247 | 2 | C0750905 | |
| Disease | IGFBP-1 measurement | 5.12e-03 | 13 | 247 | 2 | EFO_0005118 | |
| Disease | Migraine Disorders | 5.12e-03 | 13 | 247 | 2 | C0149931 | |
| Disease | Amino Acid Metabolism, Inborn Errors | 5.12e-03 | 13 | 247 | 2 | C0002514 | |
| Disease | oral microbiome measurement | 5.23e-03 | 42 | 247 | 3 | EFO_0801229 | |
| Disease | Hypertensive disease | 5.45e-03 | 190 | 247 | 6 | C0020538 | |
| Disease | mean corpuscular hemoglobin concentration | HDAC9 HK1 GALNT2 PSMD2 ZNF217 DMXL1 NEK4 VPS13A SLC22A20P MED13 RUSF1 ABCC1 KALRN MYO1B TBL1XR1 RIF1 PRDM16 ENO2 | 5.72e-03 | 1105 | 247 | 18 | EFO_0004528 |
| Disease | Left ventricular noncompaction | 5.94e-03 | 14 | 247 | 2 | C1960469 | |
| Disease | Malformations of Cortical Development | 5.94e-03 | 14 | 247 | 2 | C1955869 | |
| Disease | colonic neoplasm, overall survival | 5.94e-03 | 14 | 247 | 2 | EFO_0000638, EFO_0004288 | |
| Disease | Cortical Dysplasia | 5.94e-03 | 14 | 247 | 2 | C0431380 | |
| Disease | Familial dilated cardiomyopathy | 5.96e-03 | 44 | 247 | 3 | C0340427 | |
| Disease | hair colour measurement | HDAC9 PSMB7 PKHD1 CREB3L3 HERC2 SASH1 PODXL ZNF618 SHB PPM1G LRP1 UNC13C | 5.98e-03 | 615 | 247 | 12 | EFO_0007822 |
| Disease | Profound Mental Retardation | 6.40e-03 | 139 | 247 | 5 | C0020796 | |
| Disease | Mental deficiency | 6.40e-03 | 139 | 247 | 5 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 6.40e-03 | 139 | 247 | 5 | C0025363 | |
| Disease | homocysteine measurement | 6.75e-03 | 46 | 247 | 3 | EFO_0004578 | |
| Disease | Alopecia, Male Pattern | 6.82e-03 | 15 | 247 | 2 | C4083212 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSKCGIALGEFSTLN | 906 | Q96QE3 | |
| SLKSFDSLTGCGDII | 371 | Q8N7J2 | |
| EACAKGLVSQVFLTG | 456 | Q9Y6F7 | |
| LNSGTFAGLAKLSVC | 171 | P0C7U0 | |
| LKNTCSSGGGEFLEA | 136 | P61568 | |
| EGKGLSQSCSQRDSL | 206 | Q8IYX3 | |
| EGTSAKIQCLGKATS | 311 | Q9BXX2 | |
| DVLSGNGKVSSCTAA | 1536 | Q9NR09 | |
| CNLTVKDLLLSGSSG | 176 | Q68CJ9 | |
| DGSLILTGSVDCQAK | 271 | Q13685 | |
| ETTALVCDNGSGLVK | 6 | P68133 | |
| ACKDAGLVKSLGVSN | 156 | P51857 | |
| CEFKGSLSGSNAGIT | 356 | Q676U5 | |
| AGAAEGKVVCSSLEL | 56 | Q8IWK6 | |
| GNTAKSKEICGASLT | 741 | P51816 | |
| LECNFGASSTALKGI | 76 | O00622 | |
| GASSTALKGICRAQS | 81 | O00622 | |
| GKTTLADCLISSNGI | 31 | Q7Z2Z2 | |
| GGLQDFVLKSATLCS | 586 | Q7Z2Z2 | |
| AQNSKGIVSCSGVLE | 356 | Q96L96 | |
| RKGSSGNASEVSVAC | 381 | Q69YQ0 | |
| LTTEKVGSFCLSEAG | 166 | P45954 | |
| ALETGSRCKTSVAGA | 136 | Q5JTC6 | |
| SVDGELSGCNAAILK | 451 | Q96KQ7 | |
| LNTATEIKDGLQCGT | 376 | Q8N2N9 | |
| GLSCEGAAKVLLDTF | 111 | A0A0U1RR11 | |
| SAIKIVDFGSSCQLG | 301 | Q13627 | |
| AGVRCSGQSLKSLNA | 1341 | Q9NR16 | |
| ASLCSQVAKLLAGSG | 56 | Q9NVE4 | |
| LGGLDFLSVKNASCV | 136 | P29016 | |
| SEKSLQKLCGASSGI | 316 | Q9H4D0 | |
| KDSAEFQALCSSGLG | 661 | Q75N90 | |
| SSGEEAQSGLTVLLC | 2306 | Q9Y485 | |
| FGANAILGVSLAVCK | 106 | P09104 | |
| ILGVSLAVCKAGAAE | 111 | P09104 | |
| VASQLERCKLGSETG | 76 | Q9UQB3 | |
| NGGVLTSALNVSCLA | 721 | Q86XH1 | |
| ISACDGLKGVFQLSN | 146 | Q9UKP4 | |
| CDFGISGQLVDSIAK | 246 | P45985 | |
| NCLKAVTLSLDGGDT | 476 | Q9HC84 | |
| QGLCGAVVDLTKTSE | 786 | Q9Y620 | |
| AGQRKLTCSQDTLGS | 601 | Q9UPQ7 | |
| DGSALVKLGNTTVIC | 46 | Q96B26 | |
| CGKTLLAKAVANESG | 626 | O15381 | |
| GSGSNIDLCVISKNK | 211 | Q99436 | |
| GGKLTGTANKASLCI | 416 | P09874 | |
| ASCKDTSGEIKVLQG | 406 | Q9HD26 | |
| DLSESGQVDKASLCG | 811 | O60271 | |
| TIFLSLGGNANCEKV | 671 | Q14207 | |
| IKAEGAVAKALSTCG | 231 | Q8NGH8 | |
| VKCQTLSGSQGASAL | 896 | P32926 | |
| RVCNLIDSGTKEGAS | 366 | Q02252 | |
| VSDLDSGENGKISCS | 371 | Q9Y5F0 | |
| LTGNTLCAGGASDEK | 361 | O00592 | |
| GKTLIGKCIASQSGA | 446 | Q6PIW4 | |
| KGVVDSGGLSLNVSC | 91 | Q58FF3 | |
| AQAGDKCDFTGTLIV | 236 | Q14566 | |
| AGKTASGAGEVVRCL | 21 | P41134 | |
| GLKTSCIVTAGQLAN | 736 | Q9Y5Z7 | |
| GSADGEQNLCLSVLS | 41 | Q9NS87 | |
| KVLSKNSTGCDSGLN | 451 | Q6NUN7 | |
| KSACSLESNLEGLAG | 41 | Q09161 | |
| EGCSGRLASITVSKD | 416 | Q96Q35 | |
| GAASSSVCKLDGLIH | 1826 | Q8N201 | |
| ECGAQFSLALTKSGV | 3211 | O95714 | |
| ALCAENAKTGSQIGV | 131 | Q9NQ38 | |
| TCSKADGSGSVVLRN | 1811 | Q07954 | |
| ISANGCKVDNSSLTG | 206 | P05023 | |
| AVAGDASESALLKCI | 446 | P05023 | |
| GISSTLCKAGADSLL | 451 | O00221 | |
| GLDIKSSGSGCVKVQ | 151 | Q8N0U4 | |
| SSGCLKASTNQGAID | 281 | Q8N0U4 | |
| SNLCLDSRTAKSGGL | 536 | Q10471 | |
| DSRTAKSGGLSVEVC | 541 | Q10471 | |
| KVQEVSSDGGCEAAL | 236 | Q9BZ68 | |
| LVKDISNVGEVSCGS | 556 | Q15751 | |
| QLGAVTCVGSLDLSD | 476 | Q8ND23 | |
| LFAKAGDTLSGTCLL | 426 | Q86X55 | |
| LLAEQGGVCAVISKS | 391 | B6SEH8 | |
| LDGSSNIDCLASIGT | 121 | O00757 | |
| DQALAGSLVSSTCGV | 176 | Q8IY33 | |
| DQSILCTGESGAGKT | 191 | Q7Z406 | |
| GSSVDAAVAAALCLG | 161 | Q9UJ14 | |
| SIGFLCGTSVLDKDG | 436 | Q6PCE3 | |
| CGTSVLDKDGVSAAV | 441 | Q6PCE3 | |
| TASSLSQKICNGGLS | 356 | Q9H792 | |
| LDASNELGGICSISQ | 391 | P51957 | |
| LLSEGSVGKNKSSAC | 46 | Q16649 | |
| LTSSGQVISGDACAA | 1386 | O75037 | |
| AVVDGCGKAQNSTEL | 496 | P48506 | |
| QNTVDSDKLSGGCEL | 1636 | O60229 | |
| SDKLSGGCELTVVLQ | 1641 | O60229 | |
| QCILISGESGAGKTE | 151 | Q9HD67 | |
| LAGASKTILYSCGQD | 1136 | Q8NG31 | |
| LATSVDKGECLGGST | 341 | Q9BSJ2 | |
| ANSIKVSVSSGGDCI | 2141 | P24043 | |
| LCTGESGAGKTENTK | 171 | P35579 | |
| ASCAVEALKALLTGD | 301 | A6NGR9 | |
| NTLITSGADTAKCGI | 356 | Q8N8A2 | |
| LGGTSTISDNAKELC | 226 | P10275 | |
| VDLKRLNTTGVSAGC | 3101 | O15230 | |
| LNTTGVSAGCTADLL | 3106 | O15230 | |
| GSSVNTFGKLGCDLD | 231 | Q9NVV4 | |
| AGDILNAKTVCEGDS | 231 | A1L453 | |
| AGLAASIAGSSIINK | 726 | Q86XP1 | |
| CNVSFLLSEDGSGKG | 886 | P19367 | |
| DGSGKGAALVTAVAC | 901 | P52790 | |
| LTGVQTDKAGDISCN | 1006 | P17301 | |
| CSIAGSSLGGTLLAK | 261 | Q96ES6 | |
| AVLASSASLEGKGQL | 171 | Q53HC9 | |
| ALVGCGQIENLSFKS | 681 | Q86WI3 | |
| TCVASLKGGGISDIS | 416 | Q7Z553 | |
| CGLSLSNSLKNTGEL | 456 | Q8IV76 | |
| NEDGVLSLCSKSGQL | 2181 | Q6V1P9 | |
| VSEDKRISLAGCGAQ | 101 | Q8NGQ1 | |
| ASTSDKVLGAALAGC | 136 | O60240 | |
| LGLASTKLTCEGAVA | 366 | O75864 | |
| SAAGNCSTLGKILVQ | 6091 | Q5VST9 | |
| VASGCLDINSSVKGA | 361 | P05166 | |
| EKCGAVLSQVLGAES | 296 | Q96JP2 | |
| TEEVDKALLATGCGN | 2871 | O60494 | |
| ACLLVASGAAEGVSA | 11 | Q8NB37 | |
| FGANAILGVSLAVCK | 106 | P06733 | |
| TLESSVLCQEKGLGA | 21 | Q5TZA2 | |
| CLLSSTIAESGKSAG | 256 | Q9NPB8 | |
| SSGSEGNVKLCSLEE | 126 | P29466 | |
| QASSALDCKDSLLGG | 1446 | Q8NF50 | |
| GLSCEGAAKVLLDTF | 111 | P0DPI3 | |
| DTACSNEIGVGVSKA | 1546 | P35555 | |
| CEKGLDNAVVSTLGA | 861 | Q14CM0 | |
| GNASGTTLLEALDCI | 221 | P68104 | |
| EDISSIKGVSCGAGT | 1226 | A8TX70 | |
| IKGVSCGAGTEAQVS | 1231 | A8TX70 | |
| AIVGAGVSGLASIKC | 6 | Q01740 | |
| GLSCEGAAKVLLDTF | 111 | A0A0U1RRI6 | |
| LGIGKNVVCEKAATS | 86 | Q3B7J2 | |
| CNSAGEALDTGKQTA | 586 | Q9NSG2 | |
| CGGSAGSTVAVAVKA | 346 | P35520 | |
| GSDCVTQAGLQLLAS | 71 | P08195 | |
| GADVNKCSDEGLTAL | 316 | Q9P2S6 | |
| AIAVGDSAAKSLLQG | 311 | Q9UHN6 | |
| ASGGKAEVITCDVLL | 296 | P09622 | |
| LCAETGDGRSINVKS | 271 | P22003 | |
| ANSGCSKAIGALASS | 556 | Q86V48 | |
| SGAKVLATLCGQEST | 81 | O00187 | |
| ERAANALCAGIKVTG | 256 | Q8WWU7 | |
| TSNALKVADCVVGKG | 271 | Q69YH5 | |
| GNASGTTLLEALDCI | 221 | Q5VTE0 | |
| ATLDACSFGVTGLKL | 4551 | Q14204 | |
| FGANAILGVSLAVCK | 106 | P13929 | |
| ILGVSLAVCKAGAAE | 111 | P13929 | |
| LQSEGAAALVTKGCQ | 91 | Q96KS0 | |
| GSLNGDASVCFVKAL | 561 | O94868 | |
| GCVIELASKVASGEL | 756 | Q9UKV0 | |
| ENISSGSSLNVKAGC | 656 | P82279 | |
| SCSELEKAGAGLSSL | 261 | O95865 | |
| ASKKACDQLSLGVAA | 91 | Q13002 | |
| CQLSTGGSVAGAVKL | 111 | Q92769 | |
| TAQAALGKGCLASSF | 426 | A6NK97 | |
| NIIKAATCEGSESSG | 211 | Q9UPN4 | |
| ASVEASGEIALCKTG | 21 | P19022 | |
| GTRKQDCVLLASEGT | 141 | Q8IY42 | |
| GAACGQSLEERSKTL | 116 | Q2VPK5 | |
| IVKTLAATGTGFDCA | 76 | P11926 | |
| KAVQFGTGELCDAIS | 361 | Q96EK5 | |
| DQSILCTGESGAGKT | 171 | P35580 | |
| ATAASQGVCKLVGGA | 26 | Q86YC3 | |
| VSCGLALGAQVASLS | 1691 | Q9P2P1 | |
| ADDINKVVLCGGSSR | 326 | Q0VDF9 | |
| VSDLDSGENGKISCS | 371 | Q9UN66 | |
| GSTALLKCGLSQSQG | 41 | P43121 | |
| VVGQVGCGKSSLLSA | 676 | P33527 | |
| EACAGALQNLTASKG | 566 | Q13835 | |
| VAANLCVDSKHGATG | 461 | Q49A17 | |
| VCSGVTGAVNLAKEA | 356 | Q96Q06 | |
| KDTVCSGVTGAANVA | 716 | Q96Q06 | |
| TKDAVCSGVTGAANV | 781 | Q96Q06 | |
| DTVCSGVTGAANVAK | 816 | Q96Q06 | |
| QSVLLDSAGKACGVS | 321 | Q6NUM9 | |
| SGALCVALNKAAAGS | 71 | Q9UJJ7 | |
| SNLAKCIVSVAGGAT | 196 | Q96GQ5 | |
| LSTVSQDKQGCLGSG | 41 | Q3SY00 | |
| ICTNIESLNKGSGSL | 326 | Q9BZD2 | |
| GIKNQLLSCSADGTV | 596 | Q13033 | |
| KALDVGSGSGILTAC | 81 | P22061 | |
| IEKSASLDNGGCALT | 81 | P35610 | |
| GCALTTFSVLEGEKN | 91 | P35610 | |
| LNKCAASAAEESGAG | 221 | Q15464 | |
| NTSAVLGCLAEKLAG | 201 | Q96DX4 | |
| ETNIVCKLDSSGGAV | 316 | Q9P0V3 | |
| IDSILGARSASKTGC | 566 | Q9BVQ7 | |
| AACGGLLTKLNGTIT | 616 | O43897 | |
| CANLTNGGKSELLKS | 21 | P58417 | |
| KSGALLACGIVNSGV | 441 | Q13200 | |
| NCSLGESSKIGISDI | 1691 | Q5UIP0 | |
| GFGNLSAVTICDELK | 436 | Q9P2J5 | |
| ANISGDKLVSLGTCF | 56 | Q9Y221 | |
| LKGGNQTATVIALCS | 461 | Q5T2S8 | |
| QKSEAGSGCGSLAIL | 411 | Q7RTY7 | |
| GALNAVSIVCGKSVD | 51 | Q7Z6Z6 | |
| QLLTATGAAGDSIKA | 681 | Q9HAZ2 | |
| AGDSRCVVSEAGKAL | 346 | O15355 | |
| DCSKSQGAVGLAGVL | 461 | Q13635 | |
| LKNGTSDVLLCGNSS | 316 | Q14524 | |
| KNSTVDCNGVVSLLG | 591 | Q14524 | |
| TTAKDACVNNSALGG | 461 | Q96EA4 | |
| AGGKTQLAGLFSCTV | 346 | Q8NG04 | |
| EGASDSVLKGCTQAE | 3791 | P08F94 | |
| SGSLGLSQEKKASCG | 4041 | P08F94 | |
| LGSGGNVDACVITKT | 206 | P40306 | |
| SIVGLSGTEKDKGNC | 16 | Q13017 | |
| ASSGGLCEEATAAKV | 396 | Q9UHV7 | |
| ICGNVGSGKSSLLAA | 511 | Q96J65 | |
| KAAGEAGASLQVVSL | 576 | Q8TCX5 | |
| AAALASGCTVEIKGG | 296 | Q8IYS1 | |
| SLLDIITNCGSGFAE | 306 | Q5JPH6 | |
| DKVGASASDGSVCVL | 496 | Q9BZK7 | |
| SLKDLVSACGSGGNT | 396 | P36956 | |
| LSAAAVDKGCSVGEV | 806 | O75969 | |
| ETTALVCDNGSGLVK | 6 | P68032 | |
| AACEIQVSALSSAGG | 311 | P35612 | |
| SKILNSSEGVKESGC | 21 | Q8TBZ0 | |
| TTTDLAETQALLGCG | 671 | Q96P48 | |
| GSCFGEISILNIKGS | 516 | Q16280 | |
| DQSILCTGESGAGKT | 171 | P35749 | |
| CAGFLKIDTASLGDS | 1031 | Q7KZ85 | |
| DEISGLDLSSQIKGC | 386 | Q13610 | |
| ENLIATALCLSGSGS | 91 | Q8ND24 | |
| TALCLSGSGSQSDLK | 96 | Q8ND24 | |
| GVGRAAQALVCASAK | 21 | A0A494C1R9 | |
| GVGRAAQALVCASAK | 21 | P0CW01 | |
| GVGRAAQALVCASAK | 21 | A6NKD2 | |
| SSVAAGAQSGIEECK | 41 | Q93098 | |
| GAAKVSQFLVDGVCT | 486 | Q8N0X7 | |
| GVGRAAQALVCASAK | 21 | P0CV99 | |
| NVCEDLAGSTGLAKE | 666 | Q5T7W0 | |
| SEGHSAQICTAQLGK | 2136 | Q96RL7 | |
| GVGRAAQALVCASAK | 21 | Q01534 | |
| ATQGKALLAACTFGS | 121 | Q969K7 | |
| LDASKFSALQVCGGA | 1011 | Q8NB66 | |
| GVCSLAEGLKKNSSL | 971 | Q9HC29 | |
| ASVGNILGACLASSV | 186 | Q8NCC5 | |
| QTKCAASVGIGSNIL | 601 | Q9UBZ9 | |
| GDSGLISCSLQEQRK | 331 | Q9BW04 | |
| DCIGGTVLNISKSGS | 196 | O76021 | |
| TGAGKLRQALTTCDD | 766 | O95235 | |
| EFGDAISTASKALCG | 1421 | Q9Y490 | |
| SKALLGVCVGSGTEA | 71 | Q6NVU6 | |
| EKGSSLSSCVQNIGR | 1376 | Q6ZQQ2 | |
| SDTGKIGLINLGNTC | 436 | Q9P2H5 | |
| GIGDSLLNVKCAAQT | 626 | O75152 | |
| CALSSTLEDTLQGGV | 361 | Q96GC6 | |
| ECGKGLSSDTALIQH | 256 | Q6ZNG0 | |
| GDVTILTKLGSIDNC | 176 | P53804 | |
| AALGSRGSCSTEVEK | 61 | O75348 | |
| TTEKQSAAALCVGVG | 206 | O43847 | |
| SQEKLLVDSQGLSGC | 706 | O94885 | |
| QVGGLICKSKSAASE | 21 | Q92620 | |
| SQLGAVKLTSLACGN | 1211 | O15040 | |
| DKVGASASDGSVCVL | 506 | Q9BQ87 | |
| GVGRAAQALVCASAK | 21 | P0CV98 | |
| GVGRAAQALVCASAK | 21 | P0CW00 | |
| CSVIGAFSVAAVKGL | 231 | Q0D2K0 | |
| GGAIVSELCQALSSS | 126 | P58753 | |
| ECGKGLSSNTALTQH | 211 | Q6ZSS3 | |
| GECGKAFSQGSSLAL | 421 | Q9Y2P0 | |
| KELGETNKGSCAGLS | 331 | O75362 | |
| TLQLCQAALGASEAG | 646 | Q8TF50 | |
| DTCNQGLLALGISKS | 276 | Q6PML9 | |
| ASSVGGETLDKAVCS | 1126 | Q5VWN6 | |
| TKELLNVGVSSLCAG | 1741 | Q5VWN6 | |
| KALASTGGRSVQAAC | 56 | Q8TF42 | |
| TSVALGAQSGIEECK | 41 | Q9H1J5 | |
| SSGCIDDATRGSAVK | 1091 | O43314 | |
| ICGKTGSVGSDLQFL | 756 | Q9Y4F4 | |
| SVVAALNSDLCVSGG | 66 | Q8NA23 | |
| LNSDLCVSGGKDKTV | 71 | Q8NA23 | |
| TDLAGKRTESSGSCQ | 351 | Q6UX68 | |
| TLTFKLASGCDGSEI | 516 | Q9UEW8 | |
| QGTTKLASGEEFCSG | 341 | Q6N021 | |
| ALSAAAVGLKCFSLG | 21 | A0A286YF58 | |
| KLVSSLAECGAQGVT | 461 | Q69YN4 | |
| QNTLDSDKLSGGCEL | 1646 | O75962 | |
| ELCTGGSLKTVIAQD | 76 | Q96C45 | |
| LELKSACQVTAGGSS | 506 | Q9UNY4 | |
| DQCILITGESGAGKT | 101 | O43795 | |
| ELCSGGSVTDLVKGF | 101 | Q8NEV4 | |
| CIVISGESGAGKTEN | 426 | Q8NEV4 |